{"study_id": 101775, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of carbonyl stress and Advanced Glycation End Products (AGEs) in schizophrenia, identifying potential biomarkers for a specific patient subgroup.", "results_summary": "The study found that accumulation of AGEs like pentosidine and depletion of pyridoxal may serve as markers for a schizophrenia subgroup with carbonyl stress, suggesting potential for personalized treatment approaches.", "population_specificity": "Subpopulation of schizophrenia patients with idiopathic carbonyl stress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:32.637496+00:00"}
{"study_id": 101778, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of HMGB1 in the pathogenesis of acute and chronic sterile inflammatory conditions, including its interaction with the receptor for advanced glycation end products (RAGE).", "results_summary": "The study found that HMGB1 interacts with RAGE and other receptors, contributing to inflammation in sterile inflammatory conditions. Targeting HMGB1 reduced inflammation in disease models, suggesting potential clinical applications.", "population_specificity": "Not specified (review of existing research).", "effective_dosage": "Not available.", "study_duration": "Not applicable (review study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:32.890698+00:00"}
{"study_id": 101771, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of vitamin D supplementation on glycaemic control and quality of life in patients with type 2 diabetes mellitus, including the measurement of advanced glycation end products (AGEs).", "results_summary": "The abstract does not report specific results regarding advanced glycation end products, as the study is described as ongoing or not yet concluded.", "population_specificity": "Patients with type 2 diabetes mellitus treated with lifestyle advice, metformin, or sulphonylurea-derivatives in the Netherlands.", "effective_dosage": "50,000 IU Vitamin D3 monthly.", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:33.836343+00:00"}
{"study_id": 101777, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of SGK1 in platelet function and how Advanced Glycation End Products (AGEs) influence SGK1 expression and Ca(2+) signaling in platelets.", "results_summary": "The study found that AGEs, among other stimulators, enhance SGK1 expression, which in turn activates Ca(2+) signaling pathways, leading to increased platelet functions such as degranulation, aggregation, and thrombus formation. These findings suggest a potential link between AGEs and altered platelet activity in conditions like diabetes and chronic renal failure.", "population_specificity": "Megakaryocytes and circulating platelets (in vitro or animal model implied, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:34.687138+00:00"}
{"study_id": 101774, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize advances in understanding how dietary polyphenols and polyphenol-rich diets influence the prevention and management of type 2 diabetes, including their effects on advanced glycation end products (AGEs).", "results_summary": "The study found that dietary polyphenols, particularly anthocyanins, may help prevent type 2 diabetes by protecting pancreatic \u03b2-cells, reducing inflammation and oxidative stress, inhibiting starch-digesting enzymes, and decreasing AGE formation. However, the impact of type 2 diabetes on the pharmacokinetics and bioactivity of polyphenols remains poorly understood.", "population_specificity": "General focus on type 2 diabetes prevention and management, but no specific population details provided.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:34.983645+00:00"}
{"study_id": 101773, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether ergocalciferol (vitamin D2) improves microcirculatory endothelial function and reduces tissue advanced glycation end products in patients with chronic kidney disease and vitamin D deficiency.", "results_summary": "Ergocalciferol significantly improved endothelium-dependent microcirculatory vasodilation and reduced tissue advanced glycation end products, but did not affect sublingual microcirculatory parameters or aortic pulse wave velocity. In vitro experiments showed increased endothelial nitric oxide synthase expression and activity.", "population_specificity": "38 patients with non-diabetic chronic kidney disease (stage 3-4) and vitamin D deficiency (<16 ng/dl).", "effective_dosage": "50,000 IU weekly for one month, followed by 50,000 IU monthly.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:35.334199+00:00"}
{"study_id": 101776, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of post-translational modifications (PTMs), including advanced glycation end products, in myocardial ischemia/reperfusion injury and their impact on cardioprotection, particularly in the context of type 2 diabetes mellitus.", "results_summary": "The study found that advanced glycation end products, resulting from hyperglycemia in type 2 diabetes, contribute to aberrant PTMs that may impair cardioprotective mechanisms, such as post-conditioning, in the diabetic heart. Key proteins involved in calcium regulation were differentially modified by PTMs, influencing functional outcomes in physiological and pathophysiological states.", "population_specificity": "The study focuses on myocardial ischemia/reperfusion injury, particularly in the context of type 2 diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:35.499567+00:00"}
{"study_id": 101772, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to assess whether remote ischemic conditioning (RIC) could reduce ischemia-reperfusion injury and improve outcomes in lung transplantation, indirectly examining the role of advanced glycation end products (AGEs) in this process.", "results_summary": "The study found no significant improvement in P/F ratios or primary graft dysfunction (PGD) with RIC, though subgroup analysis suggested potential benefits for patients with restrictive lung disease. AGE-related markers (e.g., endogenous secretory receptor for AGEs) peaked post-reperfusion but were likely linked to donor organ quality rather than RIC.", "population_specificity": "60 patients undergoing bilateral sequential lung transplantation.", "effective_dosage": "Not specified (3 cycles of lower limb ischemic conditioning pre-reperfusion).", "study_duration": "Intervention occurred pre-reperfusion; follow-up included 24-hour post-transplant monitoring.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:35.689119+00:00"}
{"study_id": 101780, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in obesity-associated cardiac fibrosis and their potential contribution to fibrogenic signaling.", "results_summary": "The abstract suggests that AGEs may play a role in the development of cardiac fibrosis in obesity and metabolic dysfunction, alongside other molecular processes like oxidative stress and leptin-mediated actions. However, the relative contribution of AGEs compared to other factors remains poorly defined.", "population_specificity": "Animal models and human patients with obesity and metabolic dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:42.267455+00:00"}
{"study_id": 101779, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of vitamin D in ovarian physiology, particularly its effects on genes related to steroidogenesis, follicular development, and ovarian reserve, as well as its impact on PCOS and ART outcomes.", "results_summary": "Vitamin D supplementation in VD-deficient women with PCOS lowered abnormally elevated serum AMH levels and increased antiinflammatory sRAGE levels, suggesting improved folliculogenesis. However, data on VD's impact on IVF pregnancy rates were lacking.", "population_specificity": "Human, animal, and cell culture models, with a focus on women with PCOS and those undergoing ART.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:42.549018+00:00"}
{"study_id": 101781, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of aerobic exercise in reducing arterial stiffness and endothelial dysfunction associated with aging, particularly focusing on the mechanisms involving advanced glycation end-products (AGEs).", "results_summary": "The study found that regular aerobic exercise reduces arterial stiffness and preserves endothelial function in aging adults, partly by decreasing oxidative stress, collagen fibrosis, and advanced glycation end-products (AGEs). Exercise also maintained nitric oxide bioavailability and reduced chronic vascular inflammation.", "population_specificity": "Previously sedentary late middle-aged and older adults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:43.556627+00:00"}
{"study_id": 101786, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to identify modifiable risk factors, including Advanced Glycation End Products, that influence the risk of diabetic kidney disease (DKD).", "results_summary": "The study identified Advanced Glycation End Products as a modifiable risk factor for DKD, suggesting that managing such factors could improve prognosis in diabetic patients.", "population_specificity": "Diabetic patients at risk of DKD", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:44.240535+00:00"}
{"study_id": 101783, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to analyze the roles of HMGB1, including its interaction with the receptor for advanced glycation end products (RAGE), in physiological and pathological conditions, particularly in pediatric diseases.", "results_summary": "The abstract highlights HMGB1's involvement in inflammatory and autoimmune diseases, tumor progression, and neuroinflammation, suggesting its potential as a therapeutic target, but does not provide specific results on advanced glycation end products.", "population_specificity": "Pediatric diseases (broadly mentioned, no specific population detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:44.603435+00:00"}
{"study_id": 101782, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and their receptor RAGE in chronic immune imbalance in diabetic patients and evaluate noninvasive methods for AGEs measurement and therapeutic interventions.", "results_summary": "The study found that AGEs and RAGE contribute to chronic immune imbalance in diabetic patients, leading to ineffective inflammatory responses in diabetic wounds. Noninvasive skin autofluorescence emerged as a promising method for AGEs assessment, and anti-AGE therapies showed potential in reducing AGE-related damage.", "population_specificity": "Diabetic patients, particularly those with chronic subclinical inflammation and complications like neuropathy and atherosclerosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:44.804609+00:00"}
{"study_id": 101784, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanisms by which organophosphorus pesticides (OPs) contribute to insulin resistance and type 2 diabetes, including the role of advanced glycation end products.", "results_summary": "The study found that OPs impair glucose homeostasis, promote insulin resistance, and increase the risk of type 2 diabetes through mechanisms involving advanced glycation end products, lipid metabolite accumulation, inflammation, and oxidative stress. These processes negatively impact insulin signaling via serine kinase activation.", "population_specificity": "Not specified (general discussion of experimental and clinical data).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:45.199011+00:00"}
{"study_id": 101785, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic vascular complications, particularly their contribution to oxidative stress and PKC activation.", "results_summary": "The study found that AGEs, along with other factors like hyperglycemia and ROS overproduction, contribute to PKC activation, leading to endothelial dysfunction, impaired vasodilation, and increased vascular contractility in diabetes. PKC activation also elevates VEGF expression and NADPH oxidase activity, exacerbating oxidative stress.", "population_specificity": "Individuals with diabetes mellitus (DM) experiencing vascular complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:45.508877+00:00"}
{"study_id": 101787, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore potential mechanisms, including Advanced Glycation End Products, by which diabetes mellitus may contribute to cognitive impairment and dementia.", "results_summary": "The abstract suggests that Advanced Glycation End Products may be one of several factors involved in cognitive impairment in diabetes, but no specific results about its direct effects are provided. The study highlights the lack of approved treatments for vascular dementia or cognitive decline in diabetic patients.", "population_specificity": "Patients with diabetes mellitus (specific demographics not detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:51.258796+00:00"}
{"study_id": 101788, "supplement_id": 857, "safety_score": "80", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of a high-AGE versus low-AGE diet on endothelial function, circulating AGEs, inflammatory mediators, and AGE receptors in healthy adults.", "results_summary": "The study found that a low-AGE diet reduced serum and urine CML levels but had no significant impact on endothelial function or inflammatory mediators. A high-AGE diet showed no significant changes in CML levels or any measured health outcomes.", "population_specificity": "Healthy adults aged 50-69 years.", "effective_dosage": "Not specified (diets prepared at high or mild temperatures).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:52.363531+00:00"}
{"study_id": 101789, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the link between soluble receptor for advanced glycation end-products (sRAGE) and endothelial function during acute exacerbations of COPD and after clinical recovery.", "results_summary": "The study found that sRAGE levels and endothelial function were significantly impaired during acute exacerbations of COPD but improved after clinical recovery, with a positive association between sRAGE and endothelial function.", "population_specificity": "Patients with moderate to severe COPD admitted to the hospital due to acute exacerbations, without overt cardiovascular comorbidities (27% female).", "effective_dosage": "Not specified", "study_duration": "Measurements were taken during hospitalization and after confirmed clinical stability (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:53.864075+00:00"}
{"study_id": 101791, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore how nutrients and caloric intake, including advanced glycation end products (AGE), influence KRAS-driven pancreatic ductal carcinogenesis through metabolic stress mediators.", "results_summary": "The abstract suggests that AGE, along with other metabolic mediators like RAGE, HMGB1, and glutamine pathways, may play a role in pancreatic cancer metabolism, potentially offering new avenues for prevention and treatment. However, no specific outcomes or effects of AGE are detailed.", "population_specificity": "Not specified (general pancreatic cancer biology context).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:54.201158+00:00"}
{"study_id": 101793, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic vascular complications and identify potential therapeutic targets.", "results_summary": "The study suggests that AGEs and their interaction with RAGE contribute to diabetic vascular complications, alongside other pathways like hyperglycemia and RAAS activation. It highlights the potential of targeting Nox-derived ROS, AGE formation, and RAGE activation as superior strategies to mitigate vascular damage in diabetes.", "population_specificity": "Diabetic patients and individuals at risk for diabetic vascular complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:54.277924+00:00"}
{"study_id": 101790, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of pioglitazone and glimepiride on the RAGE system in type 2 diabetic patients.", "results_summary": "Pioglitazone significantly increased plasma esRAGE and sRAGE levels and reduced RAGE expression in mononuclear cells compared to glimepiride, independent of glucose or insulin resistance levels.", "population_specificity": "63 type 2 diabetic patients aged 20-80 years with hemoglobin A1c levels of 6.4-10.3%.", "effective_dosage": "Pioglitazone (15-30 mg/day), glimepiride (0.5-4 mg/day).", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:54.559564+00:00"}
{"study_id": 101794, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products in impairing postischemic revascularization in diabetic patients, particularly in myocardial infarction or critical limb ischemia.", "results_summary": "The study found that Advanced Glycation End Products contribute to impaired angiogenesis in diabetic patients by disrupting proangiogenic pathways and activating antiangiogenic signals, leading to worsened ischemic injury and adverse tissue remodeling. The diabetic environment also impairs the function of bone marrow-derived cells that promote angiogenesis.", "population_specificity": "Patients with diabetes mellitus, particularly those with myocardial infarction or critical limb ischemia.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:55.535926+00:00"}
{"study_id": 101792, "supplement_id": 857, "safety_score": "70", "efficacy_score": 50, "quality_score": 85, "study_goal": "To examine the safety, tolerability, and efficacy of PF-04494700, a RAGE inhibitor, in mild to moderate Alzheimer's disease.", "results_summary": "High-dose PF-04494700 (20 mg/d) was associated with adverse events and cognitive decline, while low-dose (5 mg/d) showed a good safety profile and potential but inconclusive benefit on cognitive decline. Other clinical and biomarker measures showed no differences between low-dose treatment and placebo.", "population_specificity": "Subjects with mild to moderate Alzheimer's disease (Mini-Mental State Examination score 14-26).", "effective_dosage": "High dose: 60 mg/day \u00d7 6 days, then 20 mg daily; low dose: 15 mg/day \u00d7 6 days, then 5 mg daily.", "study_duration": "18 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:57.189414+00:00"}
{"study_id": 101796, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the role of methylglyoxal and advanced glycation end-products in cardiovascular complications associated with diabetes and explore potential therapeutic targets.", "results_summary": "The study found that methylglyoxal, a precursor to advanced glycation end-products, contributes to endothelial cell damage in diabetes, and the glyoxalase system's failure exacerbates this effect. Targeting methylglyoxal may help prevent cardiovascular complications in diabetic patients.", "population_specificity": "Diabetic patients at risk for cardiovascular diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:02.378588+00:00"}
{"study_id": 101795, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) and their receptor RAGE in the pathology of osteoarthritis (OA) and rheumatoid arthritis (RA), focusing on potential diagnostic and therapeutic implications.", "results_summary": "The study found weak correlations between AGEs (such as pentosidine) and joint damage in early-stage OA, identified RAGE activation as a potential inflammatory pathway, and suggested that glyoxal- and methylglyoxal-derived AGEs may be elevated in OA and RA. Further research is needed to explore glyoxalase and dicarbonyl glycation for early diagnosis and preventive therapy.", "population_specificity": "Patients with osteoarthritis (OA) and rheumatoid arthritis (RA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:02.691097+00:00"}
{"study_id": 101801, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore novel therapeutic approaches for diabetic kidney disease (DKD), including advanced glycation end products treatments, based on recent advances in understanding DKD pathophysiology.", "results_summary": "The abstract does not provide specific results regarding advanced glycation end products treatments, only mentioning them as part of potential novel therapies for DKD.", "population_specificity": "Individuals with diabetic kidney disease (DKD).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:03.983108+00:00"}
{"study_id": 101798, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of dicarbonyl overload and AGEs in disrupting ovarian function and fertility, particularly focusing on their impact on oocyte competence.", "results_summary": "The study found that dicarbonyl stress and AGEs contribute to perturbations in the ovarian microenvironment, reducing fertility, with methylglyoxal identified as a key glycating agent. The glyoxalase system in the ovary and oocyte may help counteract this stress, suggesting AGEs as potential predictive markers or therapeutic targets.", "population_specificity": "Reproductive-age women, particularly those with PCOS or diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:03.984623+00:00"}
{"study_id": 101797, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs), particularly those derived from methylglyoxal (MG), in diabetic complications and their potential as biomarkers for predicting diabetic nephropathy progression.", "results_summary": "The study found that specific plasma AGE biomarkers (MG-H1, CEL, CML) predict fast progression of diabetic nephropathy, supporting MG's role in pathogenesis. Metformin was shown to reduce MG-related AGEs, and post-meal glucose reduction also decreased MG levels and related AGEs.", "population_specificity": "Individuals with diabetes, particularly those susceptible to diabetic complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Metformin was noted to bind and inactivate MG, reducing MG-related AGEs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:04.644760+00:00"}
{"study_id": 101802, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential of pyridoxamine and other emerging agents in combating diabetic nephropathy by targeting advanced glycation end products.", "results_summary": "The abstract suggests that current evidence is not persuasive for clinical application of these agents, though they may offer a complementary approach to RAAS blockade. The authors highlight the need for further research and combination therapies.", "population_specificity": "Individuals with diabetic nephropathy (implied, not explicitly stated).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:06.212733+00:00"}
{"study_id": 101800, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of enalapril/lercanidipine combination on emerging cardiovascular risk biomarkers, including soluble advanced glycation end products (sRAGE), in hypertensive patients.", "results_summary": "The enalapril/lercanidipine combination increased sRAGE levels more effectively than monotherapies, suggesting a potential benefit in cardiovascular risk stratification. All treatments improved sRAGE levels, with the combination showing superior efficacy.", "population_specificity": "345 hypertensive patients (120 on enalapril, 110 on lercanidipine, 115 on the combination).", "effective_dosage": "Enalapril 20 mg, lercanidipine 10 mg, or enalapril/lercanidipine 20/10 mg fixed combination.", "study_duration": "24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:06.521287+00:00"}
{"study_id": 101799, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether replacing short-acting insulin with glulisine in combination with basal insulin glargine improves glycemic control and reduces vascular injury markers, including Advanced Glycation End Products (AGEs), in diabetic patients.", "results_summary": "Switching to glulisine significantly reduced HbA1c, AGEs, sRAGE, MCP-1, and urinary albumin excretion, suggesting improved glycemic control and reduced vascular damage. The study also found correlations between changes in these biomarkers and increased treatment satisfaction.", "population_specificity": "59 diabetic patients (49 type 1, 10 type 2; mean age 52.9 \u00b1 13.3 years) with uncontrolled blood glucose (HbA1c > 6.2%).", "effective_dosage": "Multiple daily pre-meal injections of glulisine (specific dosage not stated).", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:07.511035+00:00"}
{"study_id": 101803, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in the induction and progression of diabetic medial artery calcification (MAC).", "results_summary": "The study identified AGEs as one of multiple contributing factors to diabetic MAC, alongside inflammation, oxidative stress, and hyperphosphatemia, but did not isolate their specific effects or quantify their impact. No direct therapeutic interventions targeting AGEs were tested or reported.", "population_specificity": "Individuals with diabetes (specific demographics not detailed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:11.662550+00:00"}
{"study_id": 101804, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the elimination of middle-sized uremic solutes, including advanced glycation end-products (AGEs), between conventional high-flux membranes and modified high-cut-off (HCO) membranes during dialysis.", "results_summary": "The study found that HCO membranes significantly improved the removal of high molecular AGEs compared to conventional high-flux membranes, though albumin loss was higher with HCO membranes.", "population_specificity": "12 patients undergoing dialysis (haemodialysis or haemodiafiltration).", "effective_dosage": "Not specified", "study_duration": "Each patient underwent four treatments (two with HCO and two with PF dialyzers).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:12.805821+00:00"}
{"study_id": 101806, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the prognostic value of advanced glycation end products (AGEs) as a risk marker for diabetic kidney disease (DKD) progression.", "results_summary": "The abstract identifies AGEs as an emerging risk marker for progressive kidney function loss in DKD, but notes that further work is needed to establish whether modulating AGEs improves prognosis. Currently, AGEs are considered only as risk markers, not necessarily causal factors.", "population_specificity": "Patients with diabetic kidney disease (DKD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:13.478735+00:00"}
{"study_id": 101807, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of S100A8/A9 as a biomarker and therapeutic target in cardiovascular disease, particularly its involvement in inflammation and atherosclerosis.", "results_summary": "The study found that S100A8/A9 levels correlate with cardiovascular risk factors, atherosclerosis extent, and future coronary events. It also promotes inflammation and atherogenesis, suggesting its potential as a biomarker and therapeutic target.", "population_specificity": "Humans and mice (myeloid cells, healthy individuals, myocardial infarction survivors).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:13.836158+00:00"}
{"study_id": 101805, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of S100 proteins and their interaction with Advanced Glycation End Products (RAGE) in pancreatic cancer progression and metastasis.", "results_summary": "The study found that S100 proteins interact with RAGE, p53, and p21, contributing to extracellular matrix degradation and metastasis in pancreatic cancer. S100A11, S100P, S100A2, and S100A6 were identified as significant prognostic markers, with S100A4 and S100P linked to drug resistance and clinical outcomes.", "population_specificity": "Pancreatic cancer patients, particularly those who underwent surgical resection.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:13.856771+00:00"}
{"study_id": 101808, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and their receptor RAGE in the pathophysiology of rheumatoid arthritis (RA) and identify them as potential therapeutic targets.", "results_summary": "The abstract highlights that RAGE and other inflammatory mediators play a critical role in RA pathogenesis, suggesting they could be targeted for new therapeutic options. However, specific effects or outcomes related to AGEs are not detailed.", "population_specificity": "Not specified (general focus on rheumatoid arthritis patients).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:15.586949+00:00"}
{"study_id": 101809, "supplement_id": 857, "safety_score": "70", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of TTP488, an antagonist at the Receptor for Advanced Glycation End products, as a treatment for mild-to-moderate Alzheimer's disease (AD).", "results_summary": "The study found that a 5 mg/day dose of TTP488 showed numerical and nominal significant differences favoring reduced decline in ADAS-cog scores compared to placebo, particularly in patients with mild AD. Higher doses (20 mg/day) were associated with acute, reversible cognitive worsening.", "population_specificity": "Patients with mild-to-moderate Alzheimer's disease.", "effective_dosage": "60 mg for 6 days followed by 20 mg/day; 15 mg for 6 days followed by 5 mg/day.", "study_duration": "18 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:17.283450+00:00"}
{"study_id": 101810, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of Alagebrium (an AGE-crosslink breaker) and exercise training on endothelial function, arterial stiffness, and cardiovascular risk in older individuals.", "results_summary": "Exercise training improved physical fitness and reduced lifetime cardiovascular risk but did not affect endothelial function or arterial stiffness. Alagebrium had no independent effect on vascular function and did not enhance the benefits of exercise.", "population_specificity": "48 non-exercising older individuals (mean age 70 \u00b1 4 years) without manifest diseases or medication use.", "effective_dosage": "200 mg/day of Alagebrium.", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:18.854517+00:00"}
{"study_id": 101811, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the bidirectional relationship between diabetes and periodontitis, including the role of advanced glycation end-products (AGEs) in this interaction.", "results_summary": "The study found that AGEs contribute to periodontitis in diabetic individuals through mechanisms like inflammation and bone uncoupling. Periodontal therapy may moderately improve glycemic control, suggesting a link between AGEs and diabetes complications.", "population_specificity": "Individuals with diabetes and periodontitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:20.060926+00:00"}
{"study_id": 101814, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review strategies for inhibiting HMGB1-RAGE interaction to modulate inflammatory and tumor-facilitating activity.", "results_summary": "The study found that blocking HMGB1-RAGE signaling shows promise in treating inflammatory and autoimmune diseases, with various inhibitory approaches identified, including competitive antagonists of RAGE and direct HMGB1-targeting compounds.", "population_specificity": "Not specified (review of literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:22.580486+00:00"}
{"study_id": 101812, "supplement_id": 857, "safety_score": "20", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the relationship between exogenous advanced glycation end products (AGEs), chronic inflammation, insulin resistance (IR), and type 2 diabetes (T2D), and evaluate dietary AGE restriction as a nonpharmacologic intervention.", "results_summary": "The study found that excessive consumption of AGEs contributes to chronic inflammation, IR, and T2D, and that dietary AGE restriction effectively lowers AGE levels, restores innate defenses, and improves IR.", "population_specificity": "Not specified (general discussion, likely applicable to individuals with IR, T2D, or those consuming a standard Western diet).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:23.388182+00:00"}
{"study_id": 101813, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether salsalate reduces serum levels of early and advanced glycation end products (AGEs) in people with type 2 diabetes.", "results_summary": "Salsalate lowered early glycation products (HbA1c and furosine) and CML but did not affect other AGEs (CEL, G-(1)H, MG-(1)H) and increased pentosidine levels. Changes in AGEs were not linked to renal function or inflammation markers.", "population_specificity": "Adults with type 2 diabetes (118 treated with salsalate, 109 placebo).", "effective_dosage": "3.5 g/day", "study_duration": "48 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:24.023841+00:00"}
{"study_id": 101815, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in uremic toxin accumulation and chronic kidney disease (CKD) development, focusing on gut dysbiosis and the potential benefits of probiotics.", "results_summary": "The study suggests that gut dysbiosis contributes to systemic uremic toxin loads, including AGEs, and proposes probiotics as a potential treatment to reduce these toxins and mitigate CKD progression. It also highlights the beneficial role of regulated reactive oxygen species (ROS) production in the gut.", "population_specificity": "Patients with chronic kidney disease (CKD), particularly end-stage CKD (type 5).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:24.114399+00:00"}
{"study_id": 101816, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether advanced glycation end products (AGEs) and their receptors play a role in female reproduction, particularly in polycystic ovary syndrome (PCOS) and infertility.", "results_summary": "The study found that AGEs are intricately linked to granulosa cell dysfunction, adipocyte pathophysiology, obesity, and insulin resistance in PCOS. Additionally, irregular ovarian AGE signaling may contribute to abnormal ovarian histology in PCOS and could impact assisted reproduction outcomes and ovarian reserve measures.", "population_specificity": "Women with PCOS, polycystic ovary animal models, and women without PCOS experiencing infertility.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:26.046327+00:00"}
{"study_id": 101817, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the mode of action of tasquinimod as a novel oral anti-cancer agent, focusing on its effects on the tumour microenvironment and its interaction with Advanced Glycation End Products.", "results_summary": "Tasquinimod inhibits tumour growth and metastasis by targeting the tumour microenvironment, modulating myeloid cells, and blocking interactions involving Advanced Glycation End Products. It also exhibits anti-angiogenic effects through multiple mechanisms.", "population_specificity": "Not specified (in vitro and in vivo models implied).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:27.906008+00:00"}
{"study_id": 101818, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the association between plasma biomarkers, including soluble receptor for advanced glycation end products (sRAGE), and acute respiratory distress syndrome (ARDS) diagnosis or mortality.", "results_summary": "The study found that increased levels of soluble receptor for advanced glycation end products (sRAGE) were strongly associated with ARDS diagnosis in at-risk populations (odds ratio 3.5 [1.7-7.2]). However, sRAGE was not among the top biomarkers associated with ARDS mortality.", "population_specificity": "Patients at risk for or diagnosed with acute respiratory distress syndrome (ARDS).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:28.625841+00:00"}
{"study_id": 101819, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential benefits of new antidiabetic agents (dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists) on bone health, particularly their role in inhibiting advanced glycation end products and improving skeletal outcomes in Type 2 Diabetes Mellitus (T2D).", "results_summary": "The study found that these antidiabetic agents may benefit the skeletal system by stimulating osteoblasts, inhibiting advanced glycation end products, and reducing bone resorption, though clinical evidence in humans remains insufficient for definitive conclusions.", "population_specificity": "Individuals with Type 2 Diabetes Mellitus (T2D).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:30.473289+00:00"}
{"study_id": 101820, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare tissue advanced glycation end products (AGEs) levels in kidney transplant recipients with those in CKD stage 3 and dialysis patients, and assess the impact of transplantation on AGEs.", "results_summary": "Transplant recipients had significantly lower AGEs levels than dialysis patients, similar to CKD stage 3 patients. Transplantation was associated with a reduction in AGEs, potentially contributing to lower cardiovascular risk in transplant recipients.", "population_specificity": "66 kidney transplant recipients, 1,707 CKD stage 3 patients, and 115 dialysis patients.", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 16 months post-transplantation for a small cohort.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:32.549741+00:00"}
{"study_id": 101822, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review mass spectrometry-based procedures for identifying and characterizing glycation/glycoxidation protein targets and their adducts, highlighting limitations in current proteomic approaches.", "results_summary": "The study summarizes advancements in proteomic techniques for analyzing glycation end-products but notes limitations due to the diversity, complexity, and variable abundance of these derivatives. It calls for future research to address these challenges.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:32.722057+00:00"}
{"study_id": 101821, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining exercise with alagebrium (an advanced glycation end product crosslink breaker) would improve left ventricular stiffness in sedentary older humans.", "results_summary": "Alagebrium showed a modest improvement in LV stiffness compared to placebo but had no effect on hemodynamics, LV geometry, or exercise capacity. Exercise training alone improved exercise capacity and LV mass but did not significantly impact LV stiffness.", "population_specificity": "Healthy, previously sedentary seniors (67 \u00b1 6 years; 37 female, 20 male).", "effective_dosage": "200 mg/day", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:32.818626+00:00"}
{"study_id": 101823, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare skin autofluorescence (a marker of advanced glycation end products) in Slovakian subjects with Dutch reference data and investigate the impact of physical exercise and feeding regimens on these levels.", "results_summary": "Slovaks generally had lower skin autofluorescence than Dutch Caucasians, except in the 10-19 age group. Regular physical exercise in adults and breastfeeding in infants were associated with lower skin autofluorescence levels.", "population_specificity": "1385 apparently healthy Slovakian subjects aged from a few days old to 77 years.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:33.528079+00:00"}
{"study_id": 101824, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of the receptor of advanced glycation end products (RAGE) in lung physiology and its paradoxical expression patterns during lung tumorigenesis.", "results_summary": "The study found that RAGE is critical for lung cell function and stability but is downregulated during malignant transformation, contributing to increased cancer aggressiveness. It also highlighted RAGE's role in chronic inflammation and cell communication disruption during lung tumorigenesis.", "population_specificity": "Lung epithelial cells (fetal, birth, adult) and lung tumor cells.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:35.816067+00:00"}
{"study_id": 101825, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compile evidence on the molecular mechanisms of AGEs and oxidative stress (OS) and their influence on the progression of nonalcoholic fatty liver disease (NAFLD).", "results_summary": "The study found that AGEs, particularly under hyperglycemia and lipid peroxidation, contribute to NAFLD progression by increasing oxidative stress and activating hepatic stellate cells, worsening liver fibrosis. The interaction between AGEs and oxidative stress forms a vicious cycle, with (carboxymethyl)lysine as a shared biomarker.", "population_specificity": "Not specified (general focus on NAFLD pathogenesis).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:38.275720+00:00"}
{"study_id": 101826, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of convective therapies (including high-flux hemodialysis, hemofiltration, or hemodiafiltration) versus low-flux hemodialysis on the clearance of uremic solutes, including Advanced Glycation End Products, in patients with chronic kidney failure.", "results_summary": "Convective therapies improved the clearance of Advanced Glycation End Products and other solutes, reduced cardiovascular mortality and therapy-related hypotension, but did not significantly impact cardiac parameters, blood pressure, or anemia. The long-term benefits of specific convective modalities require further study.", "population_specificity": "Patients with chronic kidney failure", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:38.513703+00:00"}
{"study_id": 101827, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of three ARBs (telmisartan, irbesartan, candesartan) in inhibiting the HMGB1-RAGE axis for stroke prevention and acute treatment.", "results_summary": "The study suggests that ARBs inhibiting the HMGB1/RAGE axis may offer a novel option for stroke prevention and treatment, but additional clinical studies are needed to verify efficacy.", "population_specificity": "Not specified (review of clinical and experimental studies from 1976-2013).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:39.627617+00:00"}
{"study_id": 101829, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the potential of medicinal herbs in attenuating and managing diabetic complications, focusing on their mechanisms related to hyperglycemia and oxidative stress.", "results_summary": "Various medicinal plants and their active compounds (flavonoids, alkaloids, phenolic compounds, etc.) were found effective in managing diabetic complications by ameliorating hyperglycemia, oxidative stress, and modulating metabolic pathways. The study highlights the need for further exploration of mechanisms and toxicity profiles.", "population_specificity": "Diabetic animals (specific human population not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:41.655545+00:00"}
{"study_id": 101828, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanistic links between Advanced Glycation End Products (AGEs) and the connection between Alzheimer's disease (AD) and type-2 diabetes mellitus (T2DM).", "results_summary": "The study suggests that AGEs, along with other factors like impaired insulin signaling and oxidative stress, may contribute to the pathological links between AD and T2DM, potentially accelerating A\u03b2 deposition and cerebrovascular inflammation. However, the exact molecular mechanisms require further investigation.", "population_specificity": "Patients with type-2 diabetes mellitus (T2DM) and Alzheimer's disease (AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:41.975927+00:00"}
{"study_id": 101830, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between plasma AGE concentration and arterial stiffness in nondialyzed patients with diabetic nephropathy and those with chronic kidney disease (CKD) without diabetes.", "results_summary": "The study found that AGE concentration and arterial stiffness (measured by PWV) were significantly higher in patients with diabetic nephropathy compared to those without diabetes and controls. A significant correlation was observed between AGEs and PWV in CKD patients, but AGEs were not independently associated with PWV in multiple regression analysis.", "population_specificity": "24 patients with CKD and diabetic nephropathy, 36 patients with CKD without diabetes, and 19 controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:43.120213+00:00"}
{"study_id": 101831, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of anti-neuroinflammatory agents, including those targeting the receptor for advanced glycation end products, as a strategy for treating Alzheimer's disease.", "results_summary": "The review highlights promising anti-neuroinflammatory agents that attenuate microglial activation or cognitive decline in vitro or in vivo, categorized by related signaling pathways, including advanced glycation end products. These agents support the development of treatments for Alzheimer's disease.", "population_specificity": "Not specified (in vitro or in vivo models, not human subjects)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:43.195922+00:00"}
{"study_id": 101832, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the biochemical properties and significance of DCXR activity in human diseases and the utility of C. elegans as a model to study DCXR biology.", "results_summary": "The study highlights DCXR's dual role in carbohydrate metabolism and detoxification, its association with diseases like pentosuria, cancers, diabetes, and male infertility, and proposes C. elegans as a model for further genetic analysis.", "population_specificity": "Not specified (focus on enzyme properties and disease implications).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:44.911996+00:00"}
{"study_id": 101834, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether dietary advanced glycation end products (AGEs) and fructose intake affect insulin sensitivity in overweight individuals.", "results_summary": "The low-AGE diet reduced urinary AGEs, fasting insulin, and insulin resistance (HOMA-IR) compared to the high-AGE diet, while fructose intake had no significant effect.", "population_specificity": "Overweight women (n=74)", "effective_dosage": "Not specified (high- vs. low-AGE diet, fructose or glucose drinks)", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:47.342679+00:00"}
{"study_id": 101836, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of pioglitazone and metformin on oxidative stress modulation, including the impact on advanced glycation end products (AGE).", "results_summary": "Pioglitazone was superior to no medication in reducing oxidative stress markers, including AGE. Compared to metformin, both drugs were equally effective in reducing AGE, but pioglitazone showed better efficacy in restoring certain enzymatic activities.", "population_specificity": "Newly diagnosed type 2 diabetes patients", "effective_dosage": "Pioglitazone 30mg daily, metformin 1000mg daily", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:49.605449+00:00"}
{"study_id": 101835, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether serum levels of the soluble receptor for advanced glycation end products (sRAGE) are associated with postoperative respiratory failure in cardiac surgery patients.", "results_summary": "Serum sRAGE levels increased significantly after cardiac surgery, with higher levels correlating with longer cardiopulmonary bypass duration and predicting postoperative respiratory failure (AUC 0.81). The optimal cutoff for predicting respiratory failure was 3656 pg/mL (sensitivity 62%, specificity 91%).", "population_specificity": "87 patients undergoing elective cardiac surgery in three university hospitals.", "effective_dosage": "Not specified (biomarker levels measured, not administered).", "study_duration": "Biomarker levels measured perioperatively; clinical data collected for 7 days postoperatively; mechanical ventilation duration tracked for 28 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:49.885894+00:00"}
{"study_id": 101838, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in vascular remodeling, particularly their association with negative remodeling in diabetes.", "results_summary": "The study found that AGEs are key substances involved in negative vascular remodeling associated with diabetes, contributing to endothelial dysfunction and inflammation. The abstract suggests that AGEs play a detrimental role in vascular health, particularly in diabetic conditions.", "population_specificity": "Not specified (general discussion of vascular remodeling mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:51.040286+00:00"}
{"study_id": 101837, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if skin advanced glycation end products (AGEs), measured via skin intrinsic fluorescence (SIF), could serve as a surrogate for multiyear mean HbA1c in predicting diabetes complications.", "results_summary": "The study found that SIF correlated significantly with mean HbA1c, age, renal function, smoking status, skin tone, and clinic latitude, suggesting it reflects known risk factors for diabetes complications. Log(SIF) showed stronger associations with mean HbA1c over longer time periods.", "population_specificity": "1,185 individuals (53% male) with type 1 diabetes, mean age 51.5 years, mean diabetes duration 29.8 years.", "effective_dosage": "Not specified", "study_duration": "Measurements taken during years 16/17 of the EDIC study.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:52.643558+00:00"}
{"study_id": 101841, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of RAGE in mediating A\u03b2 cytotoxicity and its potential as a therapeutic target for Alzheimer's disease.", "results_summary": "The study found that RAGE mediates A\u03b2 cytotoxicity, leading to neuron damage and BBB dysfunction, and suggests that attenuating RAGE activity may prevent neurotoxicity and serve as a therapeutic strategy.", "population_specificity": "Not specified (focus on cellular and molecular mechanisms).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:53.560017+00:00"}
{"study_id": 101840, "supplement_id": 857, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of alogliptin on glucose parameters, the AGE-RAGE axis, and albuminuria in Japanese type 2 diabetes patients.", "results_summary": "Alogliptin treatment significantly improved glucose parameters, reduced circulating soluble RAGE concentrations and albuminuria, and increased 1,5-anhydroglucitol levels. Circulating AGEs were reduced only in patients with baseline AGEs \u22657 U/mL.", "population_specificity": "Japanese type 2 diabetes patients (mean age 64.7 years; 67% men; mean HbA1c 7.4%).", "effective_dosage": "25 mg once daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:55.024538+00:00"}
{"study_id": 101839, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the levels of oxidative stress markers, including advanced glycation end-products (AGEs), in Alzheimer's disease (AD) patients compared to controls, and assess the impact of different treatments on these markers.", "results_summary": "The study found higher levels of advanced glycation end-products in AD patients compared to controls, indicating increased oxidative stress. Treatment with Rivastigmine showed a reduction in IL-6 levels, but AGEs were not directly linked to treatment outcomes.", "population_specificity": "21 AD patients under standard treatment and 10 controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:55.340346+00:00"}
{"study_id": 101842, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of cerebral glucose metabolism abnormalities, including potential links to Advanced Glycation End Products, in the pathophysiology of Alzheimer's disease.", "results_summary": "The study proposed that impaired cerebral glucose metabolism contributes to Alzheimer's disease through mechanisms like oxidative stress and mitochondrial dysfunction, suggesting potential diagnostic and therapeutic targets.", "population_specificity": "Alzheimer's disease patients (theoretical/pathophysiological focus, not a clinical trial).", "effective_dosage": "Not available", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:58.862171+00:00"}
{"study_id": 101843, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the harmful role of Advanced Glycation End Products (AGEs) in tissue components and investigate their potential link between periodontitis and diabetes mellitus (DM).", "results_summary": "The abstract suggests that AGEs, formed under chronic hyperglycemia, compromise tissue function by altering extracellular matrix components, potentially exacerbating periodontitis in DM patients. The paper highlights a lack of literature on AGEs' contribution to periodontal disease in DM and proposes exploring therapeutic strategies targeting AGEs.", "population_specificity": "Subjects with diabetes mellitus (DM) and periodontitis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:59.699781+00:00"}
{"study_id": 101844, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the pathological role of the AGEs/HMGB-1-RAGE system in various types of cardiovascular disease (CVD) and explore its potential as a therapeutic target.", "results_summary": "The study found that AGEs and their receptor RAGE play a central role in the pathogenesis of CVD, particularly in diabetes-related complications, by promoting inflammation and atherosclerosis. Administration of soluble RAGE (sRAGE) showed potential in inhibiting AGE-RAGE interactions and preventing atherosclerosis in animal models.", "population_specificity": "Animal models and general discussion of diabetes-related CVD in humans.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:00.217868+00:00"}
{"study_id": 101845, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize the molecular network of RAGE signaling, particularly its role in disease-related processes like inflammation, apoptosis, proliferation, and autophagy.", "results_summary": "The study highlights RAGE's upregulation in diseases such as diabetes, cardiovascular diseases, osteoarthritis, and cancer, and its regulation of critical cell processes. It also discusses therapeutic strategies to block RAGE and recent findings on novel signaling pathways like autophagy.", "population_specificity": "Not specified (focus on molecular and animal model studies).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:00.585791+00:00"}
{"study_id": 101846, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to discuss the etiology of Alzheimer's disease (AD) and propose a paradigm shift in clinical trials, including the role of Advanced Glycation End Products in AD pathophysiology.", "results_summary": "The abstract mentions Advanced Glycation End Products as part of the primary pathophysiology of AD, alongside amyloid beta pathology, mitochondrial dysfunction, and neuro-inflammation, but does not provide specific results on its effects.", "population_specificity": "AD patients, AD brain specimens, and animal studies.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:01.687072+00:00"}
{"study_id": 101847, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products (AGEs) in erectile dysfunction (ED), particularly in diabetes and aging, and evaluate potential interventions targeting AGE formation or activity.", "results_summary": "The study found that AGEs contribute to ED through mechanisms like endothelial dysfunction and reduced nitric oxide bioavailability, but clinical interventions targeting AGEs have shown disappointing results despite promising animal model data.", "population_specificity": "Primarily focused on individuals with diabetes and aging populations, as these conditions favor AGE formation and increase ED risk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:03.659448+00:00"}
{"study_id": 101849, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) as markers and potential contributors to diabetic complications, particularly retinopathy, nephropathy, and neuropathy.", "results_summary": "The study found that certain AGEs, especially the glucose/fructose-lysine/glucosepane axis, are robust markers for microvascular disease progression, particularly retinopathy, independent of glycemic control. However, limited biological and clinical data exist on glucosepane, highlighting a need for further research.", "population_specificity": "Participants from the Diabetes Control and Complications Trial (DCCT), likely individuals with diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:05.309400+00:00"}
{"study_id": 101848, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether simvastatin reduces inflammation and injury markers, including plasma receptor for advanced glycation end products, in patients undergoing esophagectomy.", "results_summary": "Simvastatin significantly reduced plasma receptor for advanced glycation end products and other biomarkers of inflammation and injury, though no significant difference was observed in the primary physiological outcome (Vd/Vt). ALI incidence was lower in the simvastatin group but not statistically significant.", "population_specificity": "Patients undergoing esophagectomy", "effective_dosage": "80 mg enterally for 4 days preoperatively and 7 days postoperatively", "study_duration": "11 days total (4 pre-op, 7 post-op)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:06.111567+00:00"}
{"study_id": 101851, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the mechanisms of cholesterol uptake, esterification, and release in macrophages to better understand macrophage foam cell formation in atherosclerosis.", "results_summary": "The abstract describes the roles of CD36, SR-A, ACAT1, nCEH, ABCA1, ABCG1, and SR-BI in cholesterol metabolism and foam cell formation but does not report specific findings on Advanced Glycation End Products.", "population_specificity": "Not specified (focus on macrophage mechanisms in atherosclerosis).", "effective_dosage": "Not available", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:09.031228+00:00"}
{"study_id": 101850, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to clarify the role of Advanced Glycation End Products (AGE) in diabetic microvascular complications and their connection to metabolic memory and macrovascular disease.", "results_summary": "The study found that AGE play a central role in diabetic microvascular complications (retinopathy, nephropathy, neuropathy) by acting as \"directors\" of damaging processes, linking intracellular and extracellular damage and amplifying oxidative stress. AGE also contribute to metabolic memory, explaining the clinical link between micro- and macrovascular complications.", "population_specificity": "Patients with type 2 diabetes (focus on microvascular complications).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:09.203749+00:00"}
{"study_id": 101852, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the role of oxidative stress, including Advanced Glycation End Products, in the pathogenesis of hematological malignancies and evaluate new oxidative stress markers.", "results_summary": "The study highlights Advanced Glycation End Products as stable and reliable markers of oxidative stress, potentially useful in cancer diagnostics and therapeutics, but does not report specific efficacy or safety outcomes.", "population_specificity": "Patients with hematological malignancies (e.g., chronic lymphocytic leukemia, Hodgkin's lymphoma, multiple myeloma) and those undergoing bone marrow transplantation.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:09.365507+00:00"}
{"study_id": 101853, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether pioglitazone could reduce ADMA levels by decreasing RAGE expression in humans with impaired glucose tolerance or type 2 diabetes.", "results_summary": "Pioglitazone significantly decreased ADMA levels, improved insulin sensitivity, and elevated HDL-C and sRAGE levels, suggesting a glucose-lowering independent mechanism. The reduction in ADMA was correlated with changes in fibronectin, indicating a potential protective role against cardiovascular disease.", "population_specificity": "48 patients with impaired glucose tolerance or type 2 diabetes.", "effective_dosage": "Not specified in the abstract.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:10.692595+00:00"}
{"study_id": 101854, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of microRNAs (miRNAs) in the pathobiology of diabetic complications, including those linked to Advanced Glycation End Products (AGEs).", "results_summary": "The abstract discusses the involvement of AGEs in diabetic complications but does not present specific findings about their effects; instead, it highlights the potential of miRNAs as diagnostic biomarkers and therapeutic targets.", "population_specificity": "Individuals with type 1 and type 2 diabetes experiencing microvascular and macrovascular complications.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:11.276710+00:00"}
{"study_id": 101855, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of NADPH oxidases (Nox) in cell injury induced by hyperglycemia and factors like Advanced Glycation End Products (AGEs) in diabetic complications.", "results_summary": "The study highlights that Nox homologues play a critical role in diabetic complications and suggests NADPH oxidases as a therapeutic target, with small-molecule inhibitors potentially preventing or retarding these complications.", "population_specificity": "Not specified (review of existing literature and experimental animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:13.013080+00:00"}
{"study_id": 101856, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of AGE/ALE formation in diabetic retinopathy and evaluate inhibitors of the AGE-RAGE system for therapeutic utility.", "results_summary": "The abstract discusses the impact of AGE/ALE formation on retinal cell function in diabetic retinopathy and mentions the evaluation of AGE-RAGE inhibitors for potential therapeutic benefits.", "population_specificity": "Diabetic patients with retinopathy", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:15.010706+00:00"}
{"study_id": 101857, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic nephropathy progression and evaluate potential therapeutic interventions targeting AGEs.", "results_summary": "The study highlights AGEs as a contributing factor to diabetic nephropathy through oxidative stress and inflammation, and mentions pyridoxamine as an AGE inhibitor among other novel therapies.", "population_specificity": "Diabetic nephropathy patients (not explicitly specified but implied by context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:15.224637+00:00"}
{"study_id": 101858, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of HMGB1 and its involvement in signaling mechanisms related to advanced glycation end-products (AGEs) in organ injury.", "results_summary": "The study found that HMGB1 is a key mediator of organ injury, contributing to both acute and chronic diseases through its interaction with AGE receptors and Toll-like receptors. Strategies targeting HMGB1 and its pathways may offer preventive and therapeutic potential for organ injury.", "population_specificity": "Not specified (general organ injury mechanisms discussed).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:18.552260+00:00"}
{"study_id": 101859, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the common pathophysiological and clinical similarities between Alzheimer's disease (AD) and diabetes mellitus (DM), focusing on the role of advanced glycation end products (AGEs) in both conditions.", "results_summary": "The study found that AD and DM share multiple pathophysiological features, including defective insulin signaling, amyloidosis, oxidative stress, and increased AGE formation, suggesting potential therapeutic overlap. It proposed that DM treatments like insulin and antioxidants might be repurposed for AD management.", "population_specificity": "Global populations affected by Alzheimer's disease and diabetes mellitus, primarily senior citizens for AD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:19.537077+00:00"}
{"study_id": 101860, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the association of advanced glycation end products (AGEs) with endothelial nitric oxide synthesis, oxidative stress, metabolic profile, and atherosclerotic risk markers in prediabetic and diabetic elderly subjects.", "results_summary": "Higher levels of AGEs, along with other biomarkers, were found in prediabetic and diabetic groups compared to controls, with strong positive associations between AGEs and fasting glucose, HbA1c, insulin resistance, and atherosclerotic risk markers. AGEs, in combination with other biomarkers, were suggested as important indicators for evaluating diabetes-related vascular complications.", "population_specificity": "Elderly subjects with impaired fasting glucose (prediabetes, n=90), type 2 diabetes mellitus (n=95), and controls (n=88).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:20.442393+00:00"}
{"study_id": 101862, "supplement_id": 857, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate the adverse effects of glucose degradation products (GDPs) in peritoneal dialysis solutions, particularly their role in forming advanced glycation end-products (AGEs) and associated complications.", "results_summary": "The study found that GDPs in peritoneal dialysis solutions contribute to the formation of AGEs, which are linked to microvascular complications, arteriosclerosis, and cellular damage. Clinical studies on low-GDP solutions showed mixed results regarding residual renal function, peritonitis, and mortality.", "population_specificity": "Patients undergoing peritoneal dialysis, particularly those with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:21.654708+00:00"}
{"study_id": 101863, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of AGEs inhibitors from natural products as a preventive strategy for lifestyle-related diseases like diabetic complications and atherosclerosis.", "results_summary": "The study found that AGEs inhibitors (e.g., benfotiamine, pyridoxamine, aminoguanidine) significantly inhibited retinopathy and neuropathy in diabetic rats, suggesting their potential for preventing diabetic complications. The abstract also highlights the preference for natural AGEs inhibitors over prescribed drugs for daily nutritional intake.", "population_specificity": "Streptozotocin-induced diabetic rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:22.360885+00:00"}
{"study_id": 101861, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to analyze the effects of rosiglitazone on circulating biomarkers, including soluble receptor for advanced glycation end products (sRAGE), in subjects with type 2 diabetes at high risk for coronary artery disease.", "results_summary": "Rosiglitazone favorably increased sRAGE levels (inversely associated with atherosclerosis) from 1.1 to 1.4 ng/mL (P = .003), while placebo showed a smaller change (1.0 to 1.1 ng/mL, P = .046). No other biomarkers related to advanced glycation end products were significantly affected by rosiglitazone.", "population_specificity": "Subjects with type 2 diabetes and high risk for coronary artery disease (mean age 56, 41% women, 66% nonwhite).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:22.518961+00:00"}
{"study_id": 101865, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers reviewed evidence for an association between Parkinson's disease (PD) and thiamine, including the role of Advanced Glycation End Products in PD pathology.", "results_summary": "The abstract suggests a potential link between thiamine levels and PD, with thiamine supplements showing beneficial clinical effects, but does not provide specific findings on Advanced Glycation End Products beyond their involvement in candidate pathways.", "population_specificity": "Elderly individuals with Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:23.642320+00:00"}
{"study_id": 101864, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 60, "study_goal": "The researchers aimed to explore the systemic and local toxic effects of Advanced Glycation End Products (AGEs) in the context of diabetic wound healing and chronic inflammation.", "results_summary": "The study found that AGEs irreversibly impair cellular and organ physiology, hinder fibroblast and endothelial cell function, and contribute to chronic inflammation and poor wound healing in diabetic patients. These effects create a self-perpetuating cycle of inflammation and tissue damage.", "population_specificity": "Patients with Type 2 diabetes mellitus, particularly those with lower extremity ulcers or impaired wound healing.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:24.846812+00:00"}
{"study_id": 101867, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in hyperglycemia-induced oxidative stress and its contribution to diabetic cardiovascular complications.", "results_summary": "The study found that AGEs, along with other pathways, contribute to reactive oxygen species (ROS) accumulation, leading to cellular damage, endothelial dysfunction, and vascular complications in diabetes. Antioxidant therapies showed mixed clinical evidence in preventing or treating these complications.", "population_specificity": "Patients with diabetes mellitus and associated cardiovascular risks.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:29.268116+00:00"}
{"study_id": 101866, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of gut microbiota and Advanced Glycation End Products (AGEs) in the pathogenesis of chronic kidney disease (CKD) and uremia, and to hypothesize the therapeutic potential of probiotics and prebiotics in managing these conditions.", "results_summary": "The study suggests that AGEs, along with other toxins generated in or introduced via the intestine, may contribute to CKD progression. It hypothesizes that probiotics and prebiotics could help maintain gut metabolic balance and reduce CKD progression, but does not provide direct experimental results on AGEs.", "population_specificity": "Patients with chronic kidney disease (CKD) and uremia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:29.444844+00:00"}
{"study_id": 101868, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of 12-week resistance training on collagen and RAGE presence in skeletal muscle of knee osteoarthritis patients, particularly in relation to NSAID and glucosamine use.", "results_summary": "Resistance training increased type IV collagen immunoreactivity in most patients and reduced type I collagen in glucosamine-treated patients. RAGE levels significantly increased only in the placebo group, suggesting glucosamine may attenuate RAGE accumulation compared to NSAID or placebo.", "population_specificity": "Patients aged 55-69 with knee osteoarthritis, divided into NSAID, glucosamine, or placebo groups.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:31.411413+00:00"}
{"study_id": 101870, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic heart failure and investigate potential therapeutic interventions targeting AGE-RAGE interactions.", "results_summary": "The study found that AGEs contribute to diabetic heart failure by promoting oxidative stress, inflammation, and extracellular matrix accumulation, leading to vascular and myocardial damage. Drug therapies targeting AGE-RAGE interactions show promise in mitigating myocardial injury.", "population_specificity": "Diabetic patients with or at risk of heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:31.553317+00:00"}
{"study_id": 101869, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore factors associated with genetic damage in chronic kidney disease (CKD) patients, including the role of advanced glycation end products (AGEs) as markers of oxidative stress.", "results_summary": "The study found that CKD patients, particularly those on peritoneal dialysis, had higher levels of genetic damage, with AGEs being one of the oxidative stress markers elevated in patients with higher micronucleus frequency. No significant difference was observed in haemodialysis patients compared to controls.", "population_specificity": "91 CKD patients (pre-dialysis, peritoneal dialysis, haemodialysis) and 61 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Cross-sectional study (no intervention duration specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:31.894514+00:00"}
{"study_id": 101871, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the direct effects of HMGB1 on the in vitro response of urothelial carcinoma cells to bacillus Calmette-Gu\u00e9rin.", "results_summary": "HMGB1 activated cell signaling pathways (NF\u03baB, NRF2, CEBP) and potentiated the cytotoxic effects of bacillus Calmette-Gu\u00e9rin, enhancing gene expression and tumor cell response. Blockade of HMGB1 or its receptor (RAGE) significantly reduced these effects.", "population_specificity": "Human urothelial carcinoma cell lines.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:32.556227+00:00"}
{"study_id": 101872, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of sweet cherry consumption on plasma concentrations of biomarkers related to chronic inflammatory diseases, including Advanced Glycation End Products.", "results_summary": "Cherry consumption significantly reduced plasma concentrations of several inflammatory biomarkers, including a 29% decrease in extracellular newly identified ligand for the receptor for Advanced Glycation End Products, and improved other markers like CRP and IL-18.", "population_specificity": "18 healthy men and women aged 45-61 with modestly elevated CRP (1-14 mg/L).", "effective_dosage": "280 g/day of Bing sweet cherries.", "study_duration": "28 days of intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:33.032595+00:00"}
{"study_id": 101873, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if plasma S100A12 levels could predict two-year all-cause mortality in hemodialysis patients and establish a scoring system for clinical use.", "results_summary": "Higher plasma S100A12 levels (\u226518.79 ng/mL) were significantly associated with increased all-cause mortality, alongside other factors like age, low serum albumin, and CVD history. The derived integer scoring system showed good discriminative power for predicting mortality.", "population_specificity": "550 maintenance hemodialysis patients (with a validation subset of 303 patients).", "effective_dosage": "Not specified (measured plasma levels, not administered).", "study_duration": "Two-year prospective follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:35.229918+00:00"}
{"study_id": 101874, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential beneficial role of vitamin D, particularly calcitriol, in Alzheimer's disease by examining its effects on advanced glycation end products and other pathways.", "results_summary": "The study suggests vitamin D, especially calcitriol, may benefit Alzheimer's disease by modulating advanced glycation end products, enhancing amyloid-\u03b2 clearance, and regulating inflammatory cytokines. The abstract highlights multiple mechanisms but does not provide specific quantitative outcomes for advanced glycation end products.", "population_specificity": "Elderly individuals with Alzheimer's disease.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:38.791461+00:00"}
{"study_id": 101875, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of RAGE and its splicing variants in various pathophysiological processes and their potential implications in human and canine diseases.", "results_summary": "The study found that RAGE and its isoforms play significant roles in immune/inflammatory disorders, Alzheimer's disease, diabetic arteriosclerosis, tumorigenesis, and metastasis. Deregulation of soluble RAGE isoforms was linked to several pathological conditions, and comparative analyses between human and canine RAGE suggested evolutionary conservation and potential for therapeutic development.", "population_specificity": "Human and canine species (focus on RAGE-mediated disorders).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:39.420517+00:00"}
{"study_id": 101876, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between Advanced Glycation End Products (AGEs) and plaque volume (PV) in patients with acute coronary syndrome (ACS), independent of diabetes mellitus (DM).", "results_summary": "High baseline AGEs levels were associated with plaque progression, independent of DM. Statin therapy reduced AGEs levels but did not correlate with changes in PV or soluble RAGE (sRAGE).", "population_specificity": "Patients with ACS undergoing intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI).", "effective_dosage": "4 mg/day of pitavastatin or 20 mg/day of atorvastatin.", "study_duration": "8-12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:41.483385+00:00"}
{"study_id": 101878, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize recent advances in the therapy of diabetic neuropathy, including the role of Advanced Glycation End Products (AGEs) inhibition through benfotiamine.", "results_summary": "The study highlights that benfotiamine inhibits AGE formation by targeting key alternative pathways (polyol, hexosamine, protein-kinase-C) and activating transketolase, suggesting a potential therapeutic role in diabetic neuropathy.", "population_specificity": "Patients with diabetic neuropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:41.650368+00:00"}
{"study_id": 101877, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of plasma sRAGE and HMGB1 in acute ischemic stroke (IS) patients and a mouse model, and to evaluate the therapeutic potential of recombinant sRAGE.", "results_summary": "Plasma levels of sRAGE and HMGB1 increased significantly after IS, with sRAGE being an independent predictor of functional outcome. Recombinant sRAGE administration reduced immune cell infiltration, improved injury outcomes in mice, and protected neurons from oxygen-glucose deprivation-induced cell death.", "population_specificity": "Acute ischemic stroke patients and a C57BL/6J mouse model of focal ischemic stroke.", "effective_dosage": "Not specified", "study_duration": "Plasma samples were collected within 48 hours post-stroke; intervention duration in mice not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:42.145082+00:00"}
{"study_id": 101880, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess whether Vitamin E supplementation combined with lifestyle intervention reduces oxidative stress and improves cardio-metabolic status in obese children with NAFLD, focusing on markers like esRAGE.", "results_summary": "Vitamin E supplementation significantly reduced oxidative stress (PGF2-\u03b1) and improved cardio-metabolic markers (esRAGE, ALT, lipid profile, HOMA-IR) compared to lifestyle intervention alone. No significant changes were observed in the control group.", "population_specificity": "Obese prepubertal children (24 treated, 21 controls) with NAFLD.", "effective_dosage": "600 mg/day of Vitamin E.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:42.521436+00:00"}
{"study_id": 101879, "supplement_id": 857, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the acute effects of oral intake of AGE-modified \u03b2-lactoglobulins (AGE-BLG) on vascular function in patients with type 2 diabetes mellitus (T2DM), comparing it to non-glycated BLG (C-BLG).", "results_summary": "AGE-BLG significantly impaired macrovascular function (reduced flow-mediated dilation) and decreased nitric oxide bioavailability, while microvascular function remained unaffected. These effects were transient but more pronounced than those caused by C-BLG.", "population_specificity": "19 patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified (beverages containing AGE-BLG or C-BLG).", "study_duration": "Acute effects measured at 90 (T90) and 180 (T180) minutes post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:44.793738+00:00"}
{"study_id": 101881, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to summarize clinical data on the role of Advanced Glycation End Products (AGEs) and their interaction with the receptor of AGEs (RAGE) in relation to blood pressure and vascular disease.", "results_summary": "The study found no evidence linking the AGE-RAGE axis to hypertension but suggested a role in vascular disease, including macrocirculation and microcirculation. The review highlights the need for more interventional studies on AGEs and vascular disease.", "population_specificity": "Diabetic subjects and individuals with vascular disease (clinical focus, excluding animal data).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:45.189240+00:00"}
{"study_id": 101882, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and the renin-angiotensin system (RAS) in diabetic retinopathy and their potential interactions for developing new treatments.", "results_summary": "The study found that both AGEs and RAS influence diabetic retinopathy, with growing evidence of cross-talk between these pathways, suggesting potential implications for new treatment strategies.", "population_specificity": "Diabetic retinopathy patients (pre-clinical and clinical studies referenced).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:47.990132+00:00"}
{"study_id": 101883, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate skin autofluorescence (SAF) levels of Advanced Glycation End Products (AGEs) during pregnancy in diabetic and non-diabetic women and assess its relation to adverse pregnancy outcomes.", "results_summary": "SAF decreased slightly during normal pregnancy but not in hyperglycemic pregnancies. SAF was higher in preexistent DM patients compared to GDM or normal pregnancy groups but showed no association with adverse pregnancy outcomes.", "population_specificity": "Pregnant women (79 with GDM, 21 with preexistent DM, and 55 without diabetes).", "effective_dosage": "Not specified", "study_duration": "Measured from 26 gestational weeks onward until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:49.391543+00:00"}
{"study_id": 101884, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of RAGE and its ligands, including Advanced Glycation End Products, in inflammation, disease, and tissue homeostasis.", "results_summary": "The study found that RAGE activation is involved in both pathological conditions (e.g., diabetes, neurodegeneration) and physiological processes like tissue repair and inflammation resolution, with effects varying by cell type and context.", "population_specificity": "Not specified (general biological mechanisms discussed).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:50.890536+00:00"}
{"study_id": 101885, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the progression of diabetic nephropathy and their potential as therapeutic targets.", "results_summary": "The study identified AGEs as one of the three major pathways contributing to diabetic nephropathy, linking them to microinflammation and extracellular matrix expansion, which are key factors in disease progression. It also highlighted AGEs as potential molecular targets for new anti-inflammatory therapeutic strategies.", "population_specificity": "Patients with diabetic nephropathy and chronic kidney disease (CKD) progressing to end-stage renal disease (ESRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:51.046876+00:00"}
{"study_id": 101887, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathophysiology of diabetic cardiomyopathy (DCM) and their potential as therapeutic targets.", "results_summary": "The study discussed AGEs as one of several diabetes-induced metabolites implicated in DCM but did not provide specific efficacy data. It highlighted the need for further research to elucidate molecular mechanisms and develop effective therapies.", "population_specificity": "Diabetic individuals at risk of or with diabetic cardiomyopathy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:51.088289+00:00"}
{"study_id": 101886, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the association between serum levels of glycated albumin (GA), sRAGE, esRAGE, and the severity of albuminuria, CI-AKI occurrence, and 1-year clinical outcomes in type 2 diabetic patients undergoing percutaneous coronary intervention.", "results_summary": "Elevated GA and reduced sRAGE/esRAGE levels correlated with increased albuminuria severity and higher CI-AKI risk, negatively impacting 1-year clinical outcomes in diabetic patients. These markers remained independently associated with adverse events after adjusting for confounders.", "population_specificity": "Type 2 diabetic patients undergoing sirolimus-eluting stent-based percutaneous coronary intervention, stratified by albuminuria severity (normo-, micro-, and macroalbuminuria).", "effective_dosage": "Not specified", "study_duration": "1-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:52.945754+00:00"}
{"study_id": 101889, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether benfotiamine, a thiamine derivative, could mitigate the effects of advanced glycation end products (AGEs) and potentially reverse Alzheimer's Disease (AD) pathology.", "results_summary": "The study found that benfotiamine reduced AGE accumulation, diminished plaque formation, decreased tau phosphorylation, and reversed memory deficits in animal models of AD. It also improved peripheral neuropathy in diabetic humans and animals by enhancing thiamine-dependent enzyme activity.", "population_specificity": "Animal models of Alzheimer's Disease and diabetic humans/animals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:54.765993+00:00"}
{"study_id": 101888, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Advanced Glycation End Products (AGEs) induce endoplasmic reticulum (ER) stress and the pathways through which they stimulate cyclooxygenase-2 (COX-2) expression in human chondrocytes.", "results_summary": "AGE-BSA induced ER stress markers (GRP78, Bag-1) and COX-2 expression in human chondrocytes, mediated through eIF2\u03b1, p38-MAPK, and NF-\u03baB pathways. RAGE knockdown and specific inhibitors (e.g., SB202190, Bay 11-7082) suppressed these effects, suggesting AGEs contribute to cartilage degradation via ER stress.", "population_specificity": "Human chondrocytes (articular cartilage cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:55.373592+00:00"}
{"study_id": 101890, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the relationship between skin autofluorescence (a marker of advanced glycation end-products, AGEs) and cardiovascular risk factors in children with chronic kidney disease (CKD).", "results_summary": "The study found that AGE accumulation (measured via sAF) was elevated in CKD children and correlated with cardiovascular markers like arterial stiffness (PWV/ht), left ventricular mass, blood pressure, and biochemical risk factors. Higher AGE levels were associated with declining kidney function and longer dialysis duration.", "population_specificity": "Children with chronic kidney disease (20 on hemodialysis, 20 on peritoneal dialysis, 36 treated conservatively) and 26 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:58.064222+00:00"}
{"study_id": 101891, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether levels of AGE-LDL in immune complexes predict incident cardiovascular disease events in patients with type 2 diabetes.", "results_summary": "The study found that higher levels of MDA-LDL in immune complexes were associated with increased risk of myocardial infarction and composite cardiovascular events, while AGE-LDL showed modest but less significant associations (HR = 1.31 for MI and 1.34 for composite endpoint).", "population_specificity": "907 patients with type 2 diabetes from the VADT cohort.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 3.7 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:58.899475+00:00"}
{"study_id": 101892, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the clinical utility of AGE cross-link breakers in preventing and managing age- and diabetes-associated disorders.", "results_summary": "The study found that AGEs contribute to oxidative stress, inflammation, and organ dysfunction, and AGE cross-link breakers may offer a novel therapeutic approach for related diseases.", "population_specificity": "General aging population and individuals with diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:00.164017+00:00"}
{"study_id": 101894, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of Ca(2+) signaling and oxidative stress, including Advanced Glycation End Products, in diabetic neuropathic pain in sensory neurons.", "results_summary": "The study found that Advanced Glycation End Products, along with oxidative stress and Ca(2+) dysregulation, contribute to diabetic neuropathic pain, with TRP channels (TRPC, TRPM, TRPV) playing a significant role.", "population_specificity": "Patients with diabetes mellitus and diabetic neuropathy, as well as animal models of type 1 and type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:00.455083+00:00"}
{"study_id": 101893, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in cartilage damage and their systemic effects in metabolic osteoarthritis.", "results_summary": "The study found that AGEs contribute to cartilage damage through oxidative stress and local effects, while systemic inflammation from glucose accumulation exacerbates osteoarthritis. AGEs are implicated in the shared mechanisms of inflammation and oxidative stress linking metabolic syndrome and osteoarthritis.", "population_specificity": "Individuals with metabolic osteoarthritis and metabolic syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:00.897508+00:00"}
{"study_id": 101895, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the characteristics of RAGE, its isoforms, ligands, and signaling pathways in the pathogenesis of ALI and ARDS, and explore its potential as a therapeutic target.", "results_summary": "The abstract describes RAGE's role in inflammation and its involvement in ALI and ARDS, highlighting sRAGE as a decoy receptor that inhibits membrane RAGE activation. It suggests RAGE as a potential therapeutic target but does not present specific efficacy or safety data.", "population_specificity": "Not specified (focus on molecular and pathological mechanisms in ALI/ARDS).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:02.663824+00:00"}
{"study_id": 101897, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize current understanding of hyperglycemia-induced cardiac mitochondrial dysfunction, focusing on oxidative stress and the role of p66Shc protein in diabetic complications.", "results_summary": "The abstract highlights that hyperglycemia drives diabetic cardiovascular complications through mechanisms like advanced glycation end-products formation, oxidative stress, and mitochondrial dysfunction, with p66Shc protein playing a key role in oxidative balance.", "population_specificity": "Not specified (general discussion of diabetic pathophysiology)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:03.874324+00:00"}
{"study_id": 101896, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether r-roscovitine treatment could reduce lung damage in ventilator-induced lung injury (VILI) by targeting polymorphonuclear neutrophil (PMN) apoptosis and lowering markers like RAGE (receptor for advanced glycation end products).", "results_summary": "R-roscovitine treatment reduced PMN influx and lowered lung damage markers (RAGE and total immunoglobulin M) in bronchoalveolar lavage fluid during lung-injurious mechanical ventilation, but did not affect cytokine or chemokine levels.", "population_specificity": "Mice subjected to mechanical ventilation (lung-protective or lung-injurious).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:04.865155+00:00"}
{"study_id": 101898, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the role of Advanced Glycation End Products (AGEs) in cardiovascular disease (CVD) risk in diabetes and evaluate the potential of soluble RAGE as a marker for CVD.", "results_summary": "The study suggests that AGEs, through binding to RAGE, contribute to vascular damage by inducing cytokine production and oxidative stress. However, data on soluble RAGE as a CVD marker are sparse and conflicting.", "population_specificity": "Individuals with diabetes and associated cardiovascular disease risk.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:06.783390+00:00"}
{"study_id": 101900, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the relevance of serum nucleosomes, HMGB1, and sRAGE as biomarkers for diagnosis, prognosis, and therapy prediction in cancer.", "results_summary": "Cancer patients had elevated serum levels of nucleosomes and HMGB1 but decreased sRAGE levels. High nucleosome and HMGB1 release, along with low sRAGE release during therapy, were associated with poor treatment response and survival.", "population_specificity": "Cancer patients compared to healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:08.358746+00:00"}
{"study_id": 101902, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review drugs targeting advanced glycation end products and their potential to treat diabetic kidney disease by interrupting pathologic mechanisms.", "results_summary": "Ten drugs showed beneficial effects in treating diabetic kidney disease, improving markers like glomerular filtration rate and proteinuria, while five demonstrated no significant benefit or prohibitive side effects. Further large-scale trials are needed to confirm these findings.", "population_specificity": "Patients with diabetic kidney disease (DKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:09.223714+00:00"}
{"study_id": 101899, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and their receptors (RAGE) in the pathogenesis of Alzheimer's disease (AD), focusing on blood-brain barrier (BBB) dysfunction and potential therapeutic strategies.", "results_summary": "The study found that BBB dysfunction in AD involves RAGE-mediated influx and LRP1-mediated efflux of amyloid-\u03b2-peptide (ABP), suggesting that targeting these pathways could regulate ABP levels in the brain. Nanodrug delivery was proposed as a potential therapeutic strategy to enhance drug delivery and neuroprotection in AD.", "population_specificity": "The study primarily discusses Alzheimer's disease pathology, with no specific human or animal population mentioned in the abstract.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:09.731452+00:00"}
{"study_id": 101901, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of the receptor for advanced glycation end products (RAGE) in mediating HMGB1-induced neuroinflammation and necrosis in neural development and neurodegeneration.", "results_summary": "The study found that RAGE and Toll-like receptors mediate HMGB1-induced neuroinflammation and necrosis, with HMGB1 playing dual roles\u2014protective in Huntington's disease but a risk factor in Alzheimer's, Parkinson's, and multiple sclerosis.", "population_specificity": "Vertebrate cells, particularly in the central nervous system during early brain development and adulthood.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:09.967945+00:00"}
{"study_id": 101903, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the inhibitory effect of L-Lysine on the nonenzymatic glycation of fibrinogen in both in vitro and in vivo conditions.", "results_summary": "The study found that glycation increased fibrinogen activity and altered its structure, while L-Lysine inhibited these changes, improving fibrinogen's function in both experimental and clinical settings.", "population_specificity": "Type 2 diabetic patients (in vivo) and in vitro experiments with fibrinogen.", "effective_dosage": "Not specified", "study_duration": "3 months (in vivo)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:11.771624+00:00"}
{"study_id": 101905, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of inflammatory mediators, including Advanced Glycation End Products, in the pathogenesis of PCOS and their connection with low-grade inflammation.", "results_summary": "The abstract mentions Advanced Glycation End Products as one of the mediators discussed in relation to PCOS, but no specific findings or effects are detailed.", "population_specificity": "Reproductive-age women with polycystic ovarian syndrome (PCOS).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:13.263276+00:00"}
{"study_id": 101904, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of RAGE in inflammatory disorders, tumor growth, diabetic complications, and Alzheimer's disease, and its potential as a therapeutic target.", "results_summary": "The study found that RAGE transports amyloid-\u03b2 toxins across the blood-brain barrier, leading to oxidative stress, inflammation, and reduced cerebral blood flow. Regulating RAGE activity could benefit Alzheimer's patients, though recent RAGE-based therapies have faced setbacks.", "population_specificity": "Not specified (discusses general mechanisms and potential treatments).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:13.507594+00:00"}
{"study_id": 101906, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of miRNAs in the pathology of diabetic complications and discuss their potential as diagnostic and therapeutic targets.", "results_summary": "The abstract does not provide specific findings about Advanced Glycation End Products but highlights their role as a contributing factor to diabetic complications alongside other factors like hyperglycemia and inflammatory cytokines.", "population_specificity": "Not specified (general discussion of diabetic complications in Type 1 and Type 2 diabetes).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:15.104977+00:00"}
{"study_id": 101907, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the role of AGEs, particularly dietary AGEs, in ESRD patients and explore potential anti-AGE therapeutic strategies.", "results_summary": "The abstract highlights AGEs' implications in aging, neurodegenerative diseases, diabetes, and chronic kidney disease but notes a lack of prospective human studies on AGEs in chronic renal replacement therapy patients. It emphasizes the need for therapeutic strategies to delay ESRD progression or improve outcomes.", "population_specificity": "End-stage renal disease (ESRD) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:17.289278+00:00"}
{"study_id": 101909, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products in diabetic vascular complications and discuss regenerative therapies for diabetic microangiopathy.", "results_summary": "The abstract highlights that Advanced Glycation End Products contribute to vascular injury in diabetes through mechanisms like oxidative stress and nitric oxide reduction, leading to conditions such as peripheral arterial disease and ischemic stroke. The review discusses pharmacological and stem cell-based therapies as potential treatments.", "population_specificity": "Diabetic patients with vascular complications.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:18.705218+00:00"}
{"study_id": 101910, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the potential role of advanced glycation end products (AGEs) in endoplasmic reticulum (ER) stress and their contribution to metabolic diseases.", "results_summary": "The study found that AGEs or their precursors may directly or indirectly induce ER stress, contributing to metabolic diseases like diabetes and cardiovascular disorders. Inhibitors of AGEs showed potential as therapeutic agents by modulating ER stress and restoring homeostasis.", "population_specificity": "Not specified (review of basic and clinical studies).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:18.748208+00:00"}
{"study_id": 101911, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of the receptor for advanced glycation end products (RAGE) in asthma and COPD, focusing on its involvement in inflammation and potential therapeutic targeting.", "results_summary": "The study found increased RAGE and its ligands in chronic airways disease, alongside reduced soluble RAGE, suggesting a role in inflammation. It highlights RAGE gene polymorphisms linked to airflow obstruction and discusses therapeutic potential.", "population_specificity": "Patients with asthma and chronic obstructive pulmonary disease (COPD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:20.981077+00:00"}
{"study_id": 101908, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of two initial insulin strategies (basal insulin alone vs. premixed insulin) on post-prandial glucose metabolism and precursors of advanced glycation end-products in type 2 diabetes patients poorly controlled on oral anti-hyperglycemic drugs.", "results_summary": "The study found that premixed insulin (lispro mix) significantly improved post-prandial glucose levels and reduced fasting and post-prandial levels of 3-deoxyglucosone (3-DG), a precursor of advanced glycation end-products, compared to basal insulin (glargine). No differences were observed in methylglyoxal (MG) concentrations.", "population_specificity": "14 subjects with type 2 diabetes suboptimally controlled on oral anti-hyperglycemic drugs.", "effective_dosage": "Once daily insulin glargine or twice-daily 75%/25% neutral protamine lispro/lispro mix.", "study_duration": "6 months (with a 12-week cross-over period for each regimen).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:21.978665+00:00"}
{"study_id": 101912, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the expression patterns of HMGB1 and RAGE (receptor for advanced glycation end products) in rat and human brains following traumatic brain injury (TBI).", "results_summary": "HMGB1 levels initially declined post-TBI but returned to baseline after 2 days, while RAGE expression increased and peaked at 1 day post-TBI. Both HMGB1 and RAGE showed distinct localization patterns in microglia and surrounding contused areas in rat and human brains.", "population_specificity": "Rats and human subjects with traumatic brain injury.", "effective_dosage": "Not specified", "study_duration": "Observations were made up to 6 days post-TBI in rats.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:23.544365+00:00"}
{"study_id": 101913, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of advanced glycation end products (AGEs) as a nontraditional risk factor in vascular calcification, particularly in patients with chronic kidney disease (CKD).", "results_summary": "The study found that AGEs, along with oxidative stress and disordered mineral metabolism, are more prevalent and severe in CKD patients, contributing to the pathogenesis of vascular calcification. These factors are associated with increased coronary artery calcification in CKD patients compared to the general population.", "population_specificity": "Patients with chronic kidney disease (CKD) and the general population.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:23.680375+00:00"}
{"study_id": 101914, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of nifedipine-telmisartan combination therapy on sRAGE plasma levels in hypertensive patients with high cardiovascular risk.", "results_summary": "The study found that nifedipine-telmisartan treatment significantly increased sRAGE plasma concentrations after 24 weeks, suggesting potential atheroprotective and anti-inflammatory benefits. sRAGE levels were not influenced by microalbuminuria or GFR in these patients.", "population_specificity": "Hypertensive patients with high cardiovascular risk and early-stage renal disease.", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:23.981240+00:00"}
{"study_id": 101915, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sevelamer carbonate could sequester cytotoxic AGEs in the gut, preventing their uptake and reducing AGE-induced abnormalities in diabetic CKD patients.", "results_summary": "Sevelamer carbonate reduced HbA1c, serum methylglyoxal, triglycerides, and markers of inflammation and oxidative stress while increasing antioxidant markers. It also reversibly bound AGE-BSA at intestinal pH but not stomach pH.", "population_specificity": "Stage 2-4 diabetic CKD patients.", "effective_dosage": "Not specified in the abstract.", "study_duration": "2 months per treatment phase with a 1-week washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:26.634550+00:00"}
{"study_id": 101916, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of the RAGE-ligand axis in heart failure and assess its potential as a therapeutic target.", "results_summary": "The study found that RAGE and its ligands are upregulated in heart injuries like ischemia/reperfusion, diabetes, and inflammation. Pharmacological or genetic inhibition of RAGE showed protective effects in animal models, and human studies suggested a correlation between RAGE ligand levels and heart failure severity.", "population_specificity": "Murine, rat, swine models, and human studies (plasma/serum analysis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:29.962069+00:00"}
{"study_id": 101917, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of copper dysregulation, including the involvement of Advanced Glycation End Products (AGEs), in diabetes-related organ damage and explore triethylenetetramine (TETA) as a therapeutic intervention.", "results_summary": "The study found that AGEs contribute to pathogenic structures in blood vessels by binding catalytically-active CuII, exacerbating oxidative stress and organ damage. TETA, as a CuII-selective chelator, showed potential in reversing copper dysregulation and preventing organ damage in diabetes.", "population_specificity": "Primarily focused on diabetes-related organ damage, with implications for heart failure and neurodegenerative diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:30.098145+00:00"}
{"study_id": 101918, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) as biomarkers for diabetes and its vascular complications, and their potential in early detection and treatment.", "results_summary": "The study highlights that AGEs, formed due to hyperglycemia and dyslipidemia, can serve as biomarkers for diabetes and its complications. Noninvasive technologies like skin autofluorescence and pulse wave analysis can detect AGE-mediated tissue damage, offering potential for early intervention.", "population_specificity": "Not specified (general discussion on diabetes and its complications)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:30.780877+00:00"}
{"study_id": 101919, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize recent advances on the roles of Advanced Glycation End Products (AGEs) in neurodegenerative diseases, particularly Alzheimer's and Parkinson's diseases.", "results_summary": "The study found that AGEs contribute to the abnormal deposition and accumulation of proteins, sustaining oxidative stress and inflammatory responses, which are linked to the pathological and clinical aspects of neurodegenerative diseases. Further research into AGEs' molecular mechanisms could aid in developing prevention and treatment strategies.", "population_specificity": "Not specified (focus on neurodegenerative diseases, particularly Alzheimer's and Parkinson's).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:31.260998+00:00"}
{"study_id": 101921, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to propose a novel dual-target nanoparticle-based treatment for diabetic nephropathy by targeting AGEs and RAGE.", "results_summary": "The study suggests that AGEs and RAGE play a key role in diabetic nephropathy pathogenesis and proposes a multifunctional nanoparticle to inhibit both targets synergistically, potentially improving therapy efficacy.", "population_specificity": "Diabetic nephropathy patients (hypothetical, as this is a proposal).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:31.831929+00:00"}
{"study_id": 101922, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine whether modulating the receptor for advanced glycation end products (RAGE) could improve outcomes in sepsis by regulating immune responses.", "results_summary": "The study found inconsistent results regarding RAGE's role in sepsis, with some strategies (e.g., antibodies, genetic deletion) showing potential but no clear consensus on whether RAGE modulation is beneficial or harmful.", "population_specificity": "Experimental models of sepsis (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:32.225097+00:00"}
{"study_id": 101920, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in peritoneal membrane damage during long-term peritoneal dialysis (PD) and explore potential interventions like benfotiamine (BF) and glyoxalase.", "results_summary": "The study found that AGEs contribute to peritoneal membrane damage and fibrosis in both rodents and humans during PD. Interventions such as benfotiamine showed success in mitigating kidney damage, suggesting potential systemic benefits beyond local peritoneal effects.", "population_specificity": "Rodents and humans undergoing long-term peritoneal dialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:32.832893+00:00"}
{"study_id": 101923, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of methylglyoxal-derived advanced glycation end products (AGEs) in the delayed healing of diabetic gastric ulcers and explore potential therapeutic inhibition.", "results_summary": "The study found that methylglyoxal-derived AGEs, particularly through modification of peroxiredoxin-VI, are associated with delayed healing of diabetic gastric ulcers, suggesting that inhibiting this modification could have therapeutic benefits.", "population_specificity": "Diabetic individuals with gastric ulcers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:35.465165+00:00"}
{"study_id": 101924, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review potential therapeutic interventions, including targeting Advanced Glycation End Products (AGEs), to prevent or delay diabetic nephropathy progression.", "results_summary": "The abstract highlights AGEs as a potential target for delaying diabetic kidney disease progression, alongside other pathways like oxidative stress and inflammation, but does not provide specific efficacy data for AGEs alone.", "population_specificity": "Patients with diabetic nephropathy or at risk of end-stage renal disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:38.978420+00:00"}
{"study_id": 101925, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the cellular mechanisms of diastolic dysfunction in various cardiovascular diseases, including the role of advanced glycation end products (AGEs).", "results_summary": "The abstract suggests that AGEs cross-linking is one of the factors investigated in the background of diastolic dysfunction, but it does not provide specific findings on their effects. The study highlights divergent mechanisms of diastolic dysfunction across different cardiac pathologies.", "population_specificity": "Not specified (review of clinical and experimental data on cardiovascular diseases).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:39.295345+00:00"}
{"study_id": 101926, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of the receptor for advanced glycation end products (RAGE) in eosinophil function and its involvement in immune responses, including allergic and malignant diseases.", "results_summary": "The study found that eosinophils express RAGE and other PRRs, which trigger immune responses such as cytokine release, oxidative burst, and cytotoxic protein release, suggesting their involvement in defense against pathogens and modulation of inflammatory and malignant processes.", "population_specificity": "Human eosinophils (in vitro or ex vivo context, not explicitly specified).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:41.034426+00:00"}
{"study_id": 101929, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in diabetic retinopathy (DR) and explore their potential as a therapeutic target for reversing hyperglycemic memory.", "results_summary": "The study suggests that AGEs contribute to the \"metabolic memory\" phenomenon in DR, where vascular damage persists despite glycemic control. Targeting AGEs may offer a beneficial approach for preventing and treating DR.", "population_specificity": "Working-age adults with type 1 and type 2 diabetes in developed nations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:41.222240+00:00"}
{"study_id": 101927, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review recent data on the role of advanced glycation end products (AGEs) in the pathogenesis of calcinosis in connective-tissue diseases, particularly systemic sclerosis and systemic lupus erythematosus.", "results_summary": "The study found elevated tissue expression of AGEs and their receptor in patients with systemic sclerosis and systemic lupus erythematosus with calcinosis, suggesting a potential role in the pathologic process. However, no specific treatment targeting AGEs was highlighted as effective.", "population_specificity": "Patients with connective-tissue diseases, particularly juvenile dermatomyositis (JDM), systemic sclerosis, and systemic lupus erythematosus with calcinosis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:41.341527+00:00"}
{"study_id": 101928, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in diabetic nephropathy, particularly their interaction with TGF-\u03b2/Smad signaling pathways.", "results_summary": "The study found that AGEs, along with other profibrotic factors, activate Smad signaling pathways, contributing to renal fibrosis in diabetic nephropathy. Smad3 was identified as pathogenic, while Smad2 and Smad7 had protective roles, suggesting potential therapeutic targets.", "population_specificity": "The study focused on diabetic nephropathy, a complication of diabetes, but did not specify human or animal models in the abstract.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:41.417144+00:00"}
{"study_id": 101930, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether circulating advanced glycation end products (AGEs), specifically plasma pentosidine, could predict future cardiovascular events in hemodialysis patients.", "results_summary": "The study found that patients in the high tertile for plasma pentosidine had a significantly higher risk for cardiovascular events (hazard risk: 1.74). The risk was more prominent in patients with low serum albumin levels, suggesting AGE levels may reflect accumulated oxidative stress and help stratify cardiovascular risk in ESRD patients.", "population_specificity": "386 hemodialysis patients (243 male, 142 female) with renal insufficiency.", "effective_dosage": "Not specified", "study_duration": "Follow-up from December 2005 to March 2010 (approximately 4.25 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:43.281039+00:00"}
{"study_id": 101931, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to explore potential therapeutic targets for chronic kidney disease (CKD), including advanced glycation end products (AGEs), but did not focus on evaluating their safety or efficacy specifically.", "results_summary": "The abstract mentions that drugs targeting advanced glycation end products are in various stages of development but provides no specific findings regarding their effects.", "population_specificity": "Patients with chronic kidney disease (CKD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:43.670449+00:00"}
{"study_id": 101933, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of RAGE and its ligands in the progression of diabetic angiopathy and explore potential therapeutic strategies targeting this axis.", "results_summary": "The study found that RAGE and its ligands are significant pathogenic triggers for vascular injuries in diabetes, with animal studies supporting their deleterious link to diabetic angiopathy. Targeting the RAGE-ligand axis may help alleviate diabetic vascular complications and reduce disease burden.", "population_specificity": "Patients with long-standing diabetes (micro- and macroangiopathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:48.475921+00:00"}
{"study_id": 101932, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether angiotensin II type 1 receptor blockers (ARBs), specifically olmesartan and telmisartan, could reduce plasma advanced glycation end product (AGE) levels in hypertensive patients on hemodialysis.", "results_summary": "Olmesartan significantly reduced systolic blood pressure and plasma pentosidine and CML levels after 24 weeks, while telmisartan showed no significant changes in these markers. Serum total free radical levels also tended to decrease in the olmesartan group.", "population_specificity": "Hypertensive patients on hemodialysis (n=24).", "effective_dosage": "Olmesartan (20 mg/day), telmisartan (40 mg/day), candesartan (8 mg/day).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:49.438391+00:00"}
{"study_id": 101936, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review molecular factors, including Advanced Glycation End Products, that link obesity and osteoarthritis, focusing on their dysregulation and potential therapeutic implications.", "results_summary": "The abstract highlights that Advanced Glycation End Products are among the molecular players implicated in the intersection of adipose tissue and joint cell biology, with dysregulation in obesity and osteoarthritis, but does not provide specific findings on their effects.", "population_specificity": "Not specified (review of existing literature on obesity and osteoarthritis).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:50.439031+00:00"}
{"study_id": 101935, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Pyridorin (Pyridoxamine dihydrochloride) could slow the progression of diabetic nephropathy by inhibiting advanced glycation end products and reducing oxidative stress.", "results_summary": "The study found no statistically significant effect of Pyridorin on serum creatinine levels overall, but suggested a potential benefit in patients with less severe renal impairment at baseline.", "population_specificity": "317 patients with proteinuric type 2 diabetic nephropathy (mean age 63.9 years, mean diabetes duration 17.6 years).", "effective_dosage": "150 mg twice daily or 300 mg twice daily.", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:51.157107+00:00"}
{"study_id": 101934, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the roles of S100A8 and S100A9 in vascular cell types and their mechanisms of action, particularly through the receptor for advanced glycation end products, to explore potential therapeutic strategies for cardiovascular diseases.", "results_summary": "The study found that S100A8/A9 proteins modulate inflammatory processes via Toll-like receptor 4 and the receptor for advanced glycation end products, with both pro-inflammatory and anti-inflammatory effects. Elevated plasma levels of S100A8/A9 predict cardiovascular events in humans, and their deletion in mice partly protects against atherosclerosis.", "population_specificity": "Humans and Apoe(-)(/)(-) mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:51.494645+00:00"}
{"study_id": 101937, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and their receptors in post-PCI restenosis and evaluate the potential of statins to mitigate these effects.", "results_summary": "The study found that AGEs and their receptors contribute to post-PCI restenosis by promoting thrombogenesis, vascular smooth muscle cell proliferation, and extracellular matrix formation. Statins were shown to lower AGEs, decrease RAGE expression, and increase sRAGE levels, thereby potentially reducing restenosis and myonecrosis.", "population_specificity": "Patients undergoing percutaneous coronary intervention (PCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:52.328999+00:00"}
{"study_id": 101938, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of S100P in tumor growth, metastasis, and invasion, particularly through its interaction with the receptor for advanced glycation end products (RAGE).", "results_summary": "The study found that S100P, which binds to RAGE, is elevated in multiple tumor cell lines and carcinomas, and it mediates tumor growth, metastasis, and invasion. S100P may serve as a diagnostic marker, prognostic indicator, and therapy target for various carcinomas.", "population_specificity": "Tumor cell lines and carcinomas (breast, pancreas, lung, ovary)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:53.015182+00:00"}
{"study_id": 101939, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether type 2 diabetes and metabolic syndrome are associated with altered myocardial structure, microvasculature, and expression of AGEs and RAGE in men with coronary artery disease.", "results_summary": "The study found that impaired diastolic function in diabetic and metabolic syndrome patients was not linked to increased myocardial fibrosis, cardiomyocyte hypertrophy, altered microvascular structure, or elevated AGE/RAGE expression, suggesting these changes may be consequences rather than causes of cardiac dysfunction.", "population_specificity": "Men with coronary artery disease undergoing coronary artery bypass graft surgery, including 13 controls, 10 diabetic, and 23 metabolic syndrome patients.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:53.485412+00:00"}
{"study_id": 101940, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in activating the Smad pathway and their contribution to renal fibrosis and inflammation.", "results_summary": "The study found that AGEs can activate the Smad pathway via both TGF-\u03b2-dependent and independent mechanisms, contributing to renal fibrosis and inflammation, with Smad3 being pathogenic while Smad2 and Smad7 are protective.", "population_specificity": "Not specified (likely animal models, given the mention of gene knockout mice).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:57.214138+00:00"}
{"study_id": 101941, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to understand the role of advanced glycation end products in age-related chondrocyte dysfunction and osteoarthritis progression.", "results_summary": "The study found that advanced glycation end products contribute to chondrocyte senescence, impairing their response to mechanical and inflammatory insults, reducing anabolic activity, and increasing proinflammatory cytokine and matrix-degrading enzyme production, which may lead to osteoarthritis.", "population_specificity": "Aging chondrocytes (in vitro or animal model implied, not explicitly stated).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:58.222114+00:00"}
{"study_id": 101943, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the mechanisms linking oxidative stress to diabetic complications and explore therapeutic opportunities involving antioxidant properties, including those related to Advanced Glycation End Products (AGEs).", "results_summary": "The study found that oxidative stress, driven by factors like AGEs, contributes to diabetic complications, and intensive management of metabolic syndrome components reduced adverse cardiovascular outcomes.", "population_specificity": "Subjects with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:59.547039+00:00"}
{"study_id": 101944, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the association between advanced glycation end products and renal aging, alongside other clinical and tissue factors.", "results_summary": "The study found that advanced glycation end products are associated with renal aging, along with other factors like angiotensin II and oxidative stress. Possible interventions such as controlling blood pressure, blood sugar, and diet may help mitigate renal aging.", "population_specificity": "General aging population, particularly those with clinical factors like hypertension, diabetes, obesity, and abnormal lipid levels.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:01.479875+00:00"}
{"study_id": 101942, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether differences in RAGE expression and its soluble form (sRAGE) underlie the differing clinical outcomes of hyperglycemia in diabetic and non-diabetic critically ill patients.", "results_summary": "The study found that sRAGE levels were higher in diabetic patients and decreased with intensive insulin therapy in this group but not in non-diabetic patients. sRAGE correlated with inflammatory markers and endothelial injury, but neither sRAGE nor inflammatory markers were associated with mortality.", "population_specificity": "76 hyperglycemic critically ill patients (33 with type-2 diabetes, 43 without diabetes) aged \u226518 years.", "effective_dosage": "Not specified", "study_duration": "Measurements were taken at ICU admission and on Days 1, 3, 5, and 7.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:01.553323+00:00"}
{"study_id": 101946, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the formation, harmful effects, and potential inhibitors of Advanced Glycation End Products (AGEs) in relation to diseases like diabetes and Alzheimer's.", "results_summary": "The study found that AGEs contribute to diabetic complications, atherosclerosis, and Alzheimer's disease, and highlighted natural products as promising inhibitors due to fewer side effects compared to synthetic compounds.", "population_specificity": "Not specified (general review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:01.750279+00:00"}
{"study_id": 101945, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to review the effect of cigarette smoking on clinical outcomes after periodontal surgical interventions, particularly focusing on how nicotine upregulates advanced glycation end product receptors and impacts periodontal healing.", "results_summary": "The study found that cigarette smoking negatively affects periodontal wound healing after surgical interventions, with compromised reductions in probing depth and gains in clinical attachment levels in smokers compared to nonsmokers. Residual recession was also significantly higher in smokers, though three case reports showed uneventful healing in smokers.", "population_specificity": "Smokers and nonsmokers undergoing periodontal surgical procedures.", "effective_dosage": "Not specified", "study_duration": "Smoking habit duration ranged from at least 5 years to 27.8 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:02.668624+00:00"}
{"study_id": 101947, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of advanced glycation end products (AGEs) in bone quality deterioration and fracture risk in type 2 diabetes mellitus (T2DM) patients.", "results_summary": "The study suggests that AGEs may contribute to bone fragility in T2DM by deteriorating bone quality rather than reducing bone mass, and proposes AGE-related markers as potential surrogates for assessing fracture risk. Current clinical practice relies on evaluating prior vertebral fractures and fracture histories until surrogate markers are validated.", "population_specificity": "Elderly patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:03.473981+00:00"}
{"study_id": 101949, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of insulin administration and hyperglycemia on mitochondrial function in peripheral tissues, including the role of Advanced Glycation End Products (AGEs) in mitochondrial impairment.", "results_summary": "The study found that hyperglycemia caused tissue-specific energy deficiencies, with cardiac tissue being most sensitive. Insulin therapy protected against mitochondrial dysfunction, and AGE accumulation was linked to reduced mitochondrial function in fibroblasts.", "population_specificity": "Streptozotocin (STZ)-induced hyperglycemic rats and human diabetic plasma samples.", "effective_dosage": "Not specified", "study_duration": "Short-term (10 days) and long-term (30 days) insulin administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:07.969490+00:00"}
{"study_id": 101948, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of tocotrienols and tocopherols on reducing advanced glycation end products (AGEs) and other cardiovascular risk factors.", "results_summary": "Tocotrienols reduced serum levels of advanced glycation end products (AGEs) and C-reactive protein (CRP) more effectively than tocopherols, with \u03b4-tocotrienol being the most potent. Both compounds lowered AGEs, but tocotrienols showed broader cardiovascular benefits, including anti-inflammatory and antithrombotic effects.", "population_specificity": "Experimental animals and potential human applications (e.g., patients undergoing angioplasty, stent implantation, or bypass surgery).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:08.980241+00:00"}
{"study_id": 101950, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) and their receptor in mediating the bidirectional relationship between diabetes mellitus and periodontitis.", "results_summary": "The study found that AGEs and their receptor are expressed in the periodontium of individuals with diabetes and appear to mediate hyperinflammatory responses and impaired tissue repair, contributing to accelerated periodontal destruction. Periodontitis also adversely affects glycemic control in diabetes, and periodontal therapy can modestly improve glycemic control.", "population_specificity": "Individuals with diabetes mellitus (type 1 and type 2) and periodontitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:10.216767+00:00"}
{"study_id": 101952, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in promoting renal damage, fibrosis, and inflammation in diabetic nephropathy, and explore potential pharmacological interventions to reduce AGEs.", "results_summary": "The study found that AGEs contribute to kidney damage, fibrosis, and inflammation in diabetic nephropathy by modifying protein structure/function and activating pathogenic mediators. Inhibitors of AGE formation showed promise in experimental models, but clinical efficacy remains unproven.", "population_specificity": "Diabetic individuals, particularly those with nephropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:11.106021+00:00"}
{"study_id": 101954, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to elucidate the molecular and cellular pathophysiologic mechanisms, structural changes, and therapeutic strategies related to diabetic cardiomyopathy, including the role of Advanced Glycation End Products.", "results_summary": "The study found that Advanced Glycation End Products contribute to increased stiffness in diabetic hearts by promoting fibrosis and connective tissue growth factor stimulation, exacerbating diabetic cardiomyopathy. Hyperglycemia-induced oxidative stress and abnormal gene expression further worsen cardiac dysfunction.", "population_specificity": "Diabetic patients with or at risk of cardiomyopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:12.282105+00:00"}
{"study_id": 101951, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether dietary advanced glycation end products (AGEs) contribute to insulin resistance in type 2 diabetes and whether AGE restriction could improve insulin sensitivity by modulating AGER1 and SIRT1 pathways.", "results_summary": "AGE restriction in type 2 diabetic patients reduced insulin resistance, inflammatory markers, and oxidative stress while restoring AGER1 and SIRT1 levels. AGEs suppressed AGER1 and SIRT1 in vitro, effects reversed by AGER1 overexpression.", "population_specificity": "18 type 2 diabetic patients (age 61\u00b14 years) and 18 healthy subjects (age 67\u00b11.4 years).", "effective_dosage": "Standard diet (>20 AGE Eq/day) vs. AGE-restricted diet (<10 AGE Eq/day).", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:12.848782+00:00"}
{"study_id": 101953, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of two peritoneal dialysis (PD) regimens (high vs. low glucose and GDP loads) on plasma levels of advanced glycation end products (AGEs) and related compounds.", "results_summary": "The low glucose and GDP regimen (NEPP) resulted in lower plasma levels of 3-DG and CEL compared to the standard glucose-based regimen (sPD). However, NEPP was associated with a steeper increase in CML and higher MGO levels.", "population_specificity": "New continuous ambulatory peritoneal dialysis (PD) patients.", "effective_dosage": "Not specified (regimens involved 4 glucose-lactate exchanges for sPD and 1 amino acid exchange, 1 icodextrin exchange, and 2 glucose-bicarbonate/lactate exchanges for NEPP).", "study_duration": "Two 24-week periods (48 weeks total).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:13.552722+00:00"}
{"study_id": 101955, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether aerobic exercise could reduce proinflammatory/-oxidative gene expression, including the receptor for advanced glycation end products (RAGE), in older adults.", "results_summary": "Older adults showed higher expression of proinflammatory/-oxidative genes, including RAGE, compared to younger adults. Aerobic exercise reduced or tended to reduce these gene expressions in older adults after two months.", "population_specificity": "Healthy young (18-33 years) and middle-aged/older adults (50-76 years).", "effective_dosage": "Brisk walking ~6 days/week, 50 min/day, at 70% of maximal heart rate.", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:13.675564+00:00"}
{"study_id": 101956, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy and explore potential therapeutic targets.", "results_summary": "The study found that AGEs accumulate in the retina due to chronic hyperglycemia, activating pro-oxidant and proinflammatory pathways via RAGE, contributing to sustained inflammation, neurodegeneration, and microvascular dysfunction in diabetic retinopathy. The AGE-RAGE axis presents potential therapeutic intervention points.", "population_specificity": "Diabetic patients with retinopathy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:17.636073+00:00"}
{"study_id": 101957, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and their interaction with HMGB1-TLR-RAGE in the inflammatory pathways associated with diabetes.", "results_summary": "The study found that AGEs, through their interaction with HMGB1-TLR-RAGE, contribute to chronic inflammation in diabetes by activating pro-inflammatory mediators and NF-\u03baB. Blocking HMGB1 or modulating this inflammatory tripod may offer a promising therapeutic approach for diabetes treatment.", "population_specificity": "Not specified (theoretical or mechanistic focus)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:18.212195+00:00"}
{"study_id": 101958, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to systematically review the association between skin autofluorescence (SAF), measured by the AGE Reader, and complications of diabetes.", "results_summary": "All seven studies reviewed showed positive associations of SAF with diabetes complications (e.g., mortality, cardiovascular issues, neuropathy, nephropathy), except retinopathy. However, studies had large clinical heterogeneity, and only three were prospective.", "population_specificity": "Patients with diabetes mellitus type 1 and type 2.", "effective_dosage": "Not specified", "study_duration": "Follow-up ranged from 3-5 years in prospective studies; others were cross-sectional.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:20.621364+00:00"}
{"study_id": 101959, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of metformin or pioglitazone on serum pentosidine levels (a marker of AGEs) in type 2 diabetes patients.", "results_summary": "Both metformin and pioglitazone significantly reduced serum pentosidine levels after 6 months, with greater percent changes compared to the control group, suggesting these agents may help prevent diabetic complications linked to AGEs accumulation.", "population_specificity": "66 Japanese patients with type 2 diabetes.", "effective_dosage": "Clinical doses (specific amounts not provided).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:21.110516+00:00"}
{"study_id": 101960, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of AGEs in vascular complications in diabetes and explore therapeutic interventions targeting the AGE-RAGE-oxidative stress axis.", "results_summary": "The study found that AGEs contribute to oxidative stress, inflammation, and thrombogenic reactions via RAGE interaction, exacerbating vascular complications in diabetes. It also identified a crosstalk between AGE-RAGE and RAS as a potential therapeutic target.", "population_specificity": "Individuals with diabetes (specific population details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:21.253937+00:00"}
{"study_id": 101961, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of the RAGE-ligand axis in liver diseases, including fibrosis, inflammation, and regeneration, and highlight open issues for future research.", "results_summary": "The study found that the RAGE-ligand axis contributes to liver fibrosis, inflammation, and regeneration, particularly after injury or transplantation, but its role in liver diseases remains unclear. Soluble RAGE may neutralize circulating ligands and reduce pathway activation.", "population_specificity": "Not specified (review of literature on liver diseases and surgical/clinical settings).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:21.826108+00:00"}
{"study_id": 101962, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if azelnidipine could protect kidney function in hypertensive CKD patients by reducing serum levels of AGE and sRAGE.", "results_summary": "Azelnidipine, but not amlodipine, reduced circulating AGE, sRAGE, proteinuria, and tubular injury markers independently of blood pressure effects. Both drugs lowered blood pressure comparably but did not affect glucose, HbA1c, lipids, or eGFR.", "population_specificity": "Nondiabetic stage I or II CKD patients already treated with angiotensin II receptor blockers.", "effective_dosage": "16 mg azelnidipine or 5 mg amlodipine once daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:24.339872+00:00"}
{"study_id": 101963, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to explore potential mechanisms linking diabetes mellitus (DM) and Alzheimer disease (AD), focusing on brain insulin signaling and cerebrovascular alterations involving advanced glycation end products (RAGE).", "results_summary": "The study suggests that DM may contribute to AD progression through altered brain insulin signaling and cerebrovascular dysfunction, rather than solely through beta-amyloid peptide modulation. Interactions between RAGE and A\u03b2 peptides may play a role in this dysfunction.", "population_specificity": "Mouse models and human clinicopathological studies (diabetic patients and AD pathology).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:24.379877+00:00"}
{"study_id": 101964, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore potential mechanisms, including Advanced Glycation End Products, underlying the increased cancer risk in diabetics and the association with antidiabetic drug therapy.", "results_summary": "The abstract suggests Advanced Glycation End Products as a potential mechanism for increased cancer risk in diabetics but does not provide specific findings on its effects. The study also notes inconclusive data on cancer risk with certain hypoglycemic medications and potential inhibitory effects of metformin and rosiglitazone on cancer progression.", "population_specificity": "Diabetics, particularly type 2 diabetes patients.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:27.217744+00:00"}
{"study_id": 101965, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of non-surgical periodontal therapy on inflammatory biomarkers, including sRAGE, in poorly controlled type 2 diabetes mellitus patients with periodontal disease.", "results_summary": "The study found small changes in plasma sRAGE levels after treatment, but no significant effect on sRAGE, IL-6, or CRP. Periodontal therapy improved clinical parameters and moderately reduced HbA1c.", "population_specificity": "Poorly controlled type 2 diabetes mellitus patients with periodontal disease (n=28).", "effective_dosage": "Not specified for sRAGE; minocycline was administered subgingivally (exact dosage not mentioned).", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:29.014282+00:00"}
{"study_id": 101968, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to clarify the role of glyoxalase 1 in psychiatric disorders and its relationship with dicarbonyl glycation and advanced glycation end products.", "results_summary": "The study found inconsistent associations between glyoxalase 1 expression and anxiety-related behavior in mice, suggesting that dicarbonyl substrate concentration may be a more critical factor in psychiatric disorders than glyoxalase 1 levels alone.", "population_specificity": "Clinical studies (humans with major depression, panic disorders, schizophrenia) and mouse models (trait anxiety).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:30.482413+00:00"}
{"study_id": 101967, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether irbesartan treatment affects plasma levels of AGEs (CML and CEL) in hypertensive patients with type 2 diabetes and microalbuminuria.", "results_summary": "The study found no significant changes in plasma CML and CEL levels over time in either the irbesartan or placebo group, indicating no effect of irbesartan on these AGEs. Mean differences between groups were negligible and not statistically significant.", "population_specificity": "Hypertensive patients with type 2 diabetes and microalbuminuria.", "effective_dosage": "300 mg irbesartan daily.", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:30.768559+00:00"}
{"study_id": 101966, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if reducing advanced glycation end-products (AGEs) through dietary and pharmaceutical interventions could improve obesity-related renal dysfunction.", "results_summary": "A low-AGE diet improved renal function and inflammatory markers in overweight/obese individuals. In mice, AGE-lowering treatment (alagebrium) and RAGE deletion improved renal function, inflammation, and oxidative stress, while also reducing weight gain and improving glycemic control.", "population_specificity": "Overweight and obese individuals (BMI 26-39 kg/m\u00b2) and obese mice on a high-fat, high-AGE diet.", "effective_dosage": "Not specified", "study_duration": "2 weeks (human trial); duration in mice not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:31.568318+00:00"}
{"study_id": 101969, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of lycopene on soluble receptor for advanced glycation end products (sRAGE) levels in blood and seminal plasma in normospermic males.", "results_summary": "Lycopene administration significantly decreased sRAGE levels in seminal plasma in both fertile volunteers and normospermic male partners from infertile relationships, but had no significant effect on sRAGE in blood plasma. The findings suggest selective local uptake of lycopene in the male reproductive tract, potentially suppressing oxidative stressors.", "population_specificity": "15 fertile volunteers and 13 normospermic male partners from infertile relationships.", "effective_dosage": "20 mg of lycopene daily.", "study_duration": "12 weeks per treatment phase, with a crossover for an additional 12 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:32.832345+00:00"}
{"study_id": 101971, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of sevelamer and calcium carbonate on coronary artery calcification and advanced glycation end products (AGEs) in hemodialysis patients.", "results_summary": "Sevelamer slowed the progression of coronary artery calcification and suppressed AGE accumulation compared to calcium carbonate, with a significantly lower increase in calcification scores and pentosidine levels.", "population_specificity": "183 adult hemodialysis patients with a mean vintage of 118 \u00b1 89 months.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:33.780007+00:00"}
{"study_id": 101970, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) as a pathophysiological factor linking heart and renal failure, and their potential as a treatment target in heart failure patients.", "results_summary": "The study found that AGE accumulation is associated with diastolic dysfunction and renal failure, particularly in elderly, diabetic, and renal failure patients, suggesting a role in the development and progression of diastolic heart failure. The abstract also hints at AGE intervention as a possible treatment strategy for heart failure.", "population_specificity": "Elderly patients, diabetic patients, and patients with renal failure.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:34.206861+00:00"}
